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ABSTRACT   
Title: Quality of life and treatment outcome under inhalation sedation  
AIM: 
To assess the outcome of treatment and changes in quality of life (QoL) following 
comprehensive dental treatment using nitrous oxide inhalation sedation. 
METHODS 
Patients attending the Sedation Unit at the Leeds Dental Institute were asked to 
participate in the study. Baseline questionnaires included a quality of life (QoL) 
assessment (COHIP-SF19) and the p-IOSN tool (indication of sedation need). 
Participants were followed up to evaluate the outcome of their treatment. Those who 
completed treatment as planned completed a second QoL assessment at least 2 weeks 
following their last appointment.  
RESULTS: 
In total, 97 patients were recruited (44 males and 53 females), and of these 47 completed 
treatment as planned with 31 completing  a 2nd QoL assessment, 18 are currently 
undergoing treatment, and 20 were referred to GA. There was a statistically significant 
improvement in QoL following treatment (p value= 0.000), with the largest effect size 
noted in the “oral health well-being” domain. When not controlling for other factors, a 
change from high to low anxiety was significantly associated with high baseline QoL (B= 
6.632 p value = 0.023). Changing from high to low sedation need decreased the likely 
need for referring to GA and not completing treatment as planned (B -1.788 p value 0.05). 
CONCLUSION: 
Rendering the child dentally fit improved QoL. Using anxiety, gender, age group or 
sedation need as measures could not accurately predict the treatment outcome of the 
child or the baseline QoL scores, when controlling for sedation need and anxiety. 
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1.0 LITERATURE REVIEW 
Anxiety is defined as ‘a feeling of worry, nervousness, or unease about something with 
an uncertain outcome’. Fear and anxiety are common in the dental setting, affecting 9.4% 
of children (Carrillo‐Díaz et al., 2013a). However, other studies reported it to be as high 
as 44% for low to moderate fear and 10% for high fear (Taani et al., 2005). Children are 
not able to express anxiety and fear as effective as adults; this can affect their behaviour 
during the treatment and the child may be labelled as “unco-operative” (Chadwick, 2002). 
With the adult patient who suffers from dental anxiety, they were often treated under 
intravenous sedation (IV) (Davies et at., 2011). 
Although the terms “dental anxiety”, “dental phobia”, and “dental fear” are sometimes 
used synonymously, they are different entities all together. Dental anxiety is a term that 
used to describe all types of dental-related fears and phobias. A “phobia” is classified as 
an anxiety related disorder where the actual fear interferes with the patient’s everyday 
life. Fear, on the other hand, is not as extreme (Porritt et al., 2013). However, Klingberg 
and Broberg (2007) described dental anxiety as a state of apprehension relating to the 
dental treatment in which something dreadful is going to happen, coupled with a sense 
of loss of control. Both anxiety and fear are considered primitive emotions which can be 
beneficial in maintaining the safety and well-being of healthy individuals; anxiety 
increases sensitivity to external stimuli, while fear stimulates avoidance behaviour 
(Sylvers et al., 2011). A diagnosis of “phobia” can only be made when certain criteria are 
met, based on the Diagnostic and Statistical Manual of Mental Disorders (DSM–IV) 
published by the American Psychiatric Association (1994): 
 Marked and persistent fear on an identifiable situation and/or object 
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 When exposed to the phobia, an immediate anxiety response is seen (e.g. panic 
attacks in adults and tantrums, crying, and clinging in children) 
 The patient knows that the fear of the object is extreme and irrational. This may 
be difficult for children. 
 The stimulus is either avoided or endured with great apprehension 
 The phobia significantly interferes with every-day routine, social-life, or 
occupation. There is increased grief in having a phobia 
 The patient must have had the symptoms for 6 months, if below 18 years of age. 
 No presence of other mental disorders 
1.1 Anxiety and Fear 
1.1.1 Aetiology of fears: 
Several theories have been developed to discuss how phobias are acquired; however, 
many of the previous and current theories do not seem to explain certain critical aspects 
of phobia development. In order to characterise an object or situation as a phobia, there 
are several features it must follow. These include a severe reaction evoked by the feared 
stimulus, the multiple pathways fear is “learnt”, the disproportionate distribution of fears 
across various probable stimuli, and the differences between individuals in terms of their 
fear expression in spite of similar experiences. This led to new theories that were 
proposed or in some cases, old theories were amended (Armfield, 2006). 
Armfield (2006) discussed multiple theories of genesis of phobia and their criticism: 
1. Classical conditioning theory. This theory states that a phobia is formed when a 
previously neutral stimulus is paired with an aversive response and hence 
becomes fear evoking. This may stimulate a motivational drive to avoid the 
stimulus (Armfield, 2006). However, critics of this theory stated that fear was 
conditioned and not phobia. Moreover, certain aspects of phobia are not 
covered. These include the ease of acquisition, the irrationality of phobia, the 
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uneven distribution of potentially “fear relevant” stimuli, and the resistance to 
elimination of the phobia (Seligman, 1971). 
2. Preparedness model. This theory is based on Seligman (1971) who proposed 
the 4 discrepancies concerning the classical conditioning theory. The process of 
fear development, according to this theory, is a “biologically prepared learning”; 
the fear evoking stimulus is associated with a sense of danger and has been 
throughout human history. This theory is based on 3 assumptions. The first is 
that phobias are from the experience of an initially neutral stimulus that is linked 
to an aversive event. Secondly, the stimuli can be in any stage of preparedness 
from “prepared” to “contra-prepared”. Finally, the prepared neutral stimulus has 
some biological significance in order to be fear evoking (spiders and snakes are 
fear evoking so can be prepared for fear). Critics of the “Preparedness Model” 
state that survival relevance, a stimuli that is associated with danger, is not the 
only factor. After controlling for dangerousness and unpredictability, it was found 
that survival relevance was not related to fear development (Merckelbach, 1988). 
3. The Non-associative account of fear acquisition. This theory is a variation of the 
preparedness theory. It states that people are born with innate fears and learn 
how to overcome them. Clinical phobias are thought to occur later in life and are 
due to the failure of habituation of the fear (Armfield, 2006). Critics of this theory 
believe that results of previous studies conducted could have been explained by 
other theories (Davey, 2002). 
4. Davey’s contemporary conditioning model. This model was proposed in order to 
aid in explaining why many individuals do not develop a phobia after a traumatic 
life event is experienced and also the irregular distribution of phobias within a 
population. This theory states that a conditioned stimulus will prompt a “cognitive 
representation” of an unconditioned stimulus. This is done through learned 
associations. Additionally, early exposure to the conditioned stimulus, before it 
is paired with the unconditioned stimulus has an inhibitory property (Davey, 
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1989). This is known as latent inhibition. Davey (1989) went on to study dental 
fear and noted that patients with trauma or painful experience and did not show 
signs of fear reported having previous history of negative experiences. 
Moreover, he states that certain people following a traumatic experience use 
“unconditioned stimulus devaluation” in which the unconditioned stimulus is 
neutralised by various coping strategies and eliminate the fear. Critics of this 
theory state that coping strategies like distancing oneself increased worry and 
fear (Folkman and Lazaras, 1988). 
5. Cognitive theories of fear acquisition. An example is Bandura’s self-efficacy 
theory (Bandura 1977), which states that the person’s self-efficacy in executing 
a certain action that is connected to the phobic stimulus, and the outcome of 
executing the action on the phobia are critical in its development. However, no 
link has been established between behaviour development and self-efficacy and 
also fails to consider the roles of anxiety and fear.  A second theory of cognitive 
fear acquisition is Beck and Emery’s theory of maladaptive cognition. It states 
that anxious people are fixated on the threat of harm and danger from the phobia. 
This plays an essential role in not only the aetiology but also the maintenance of 
the phobia, which may make eliminating it difficult (Armfield, 2006). 
6. The three pathways of Rachman. The “traditional” classical conditioning theory 
does not account for the absence of fear in some people when a fear evoking 
stimulus is present, and it does not account for unfair distribution of fear. It also 
fails to explain the acquisition of fear vicariously (Armfield, 2006). Therefore, 
Rachman (1977) theorised three possible pathways. The first is classical 
conditioning, where fear is acquired through conditioning. The fear is 
strengthened by number of repetitive exposure to the fear evoking stimulus and 
the intensity of the fear and/or pain associated with the stimulus there can also 
be a secondary stimulus which is similar to the primary stimulus that can elicit a 
similar reaction. The second pathway is vicarious acquisition, where fear is 
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acquired as a result of indirect exposure of a stimulus, which is linked to a 
terrifying experience. There is no history of prior exposure to the fear evoking 
stimulus. (Rachman, 1977). The same method is also used to learn behavioural 
traits and emotional responses (Bandura et al., 1969). The final pathway 
proposed by Rachman (1977) is “fear acquisition by transmission of information 
and/or instructions”. Similar to vicarious acquisition, there may not be any history 
of past experience with the stimulus. The fear in this case is more unlikely to be 
severe. This method of fear acquisition is the basis for common fears. 
Rachman’s theory has been supported by the literature. (ten Berge et al., 2002) 
1.1.2 Aetiology of Dental Anxiety: 
Dental anxiety has a multifactorial aetiology, with numerous modifying factors. These 
include the child’s temperament to fear, sensitivity to pain, negative emotions, and coping 
styles. Attitude of the parent’s negative information and previous painful experiences can 
play a role with coping strategies (Majstorovic and Veerkamp, 2004). One classification 
of the aetiology of dental fear is based on dividing it into two groups: endogenous, related 
to general fear, and exogenous, related to conditioning. The latter is more common in 
children (ten Berge et al., 2002). However, it has been reported that dental fear is linked 
to certain phobias like the fear of flying, heights, and enclosed spaces (Milgrom at al., 
1995).  Another classification is based on the cause of the specific phobias. They include 
the following (Liddell and Locker, 2000): 
 Patients with a conditioned fear from a particular stimulus 
 Patients with multi-phobic or trait anxiety symptoms 
 Patients with anxiety about a specific part of dental treatment 
 Patients who doubt members of the dental personnel 
Although most anxiety related disorders have a heritable component, the heritability of 
dental anxiety and fear is poorly understood. There is, however, an environmental 
component, in which dental care that was either painful or unpleasant, may contribute to 
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dental anxiety and fear in both adults and children (Ray et al., 2010; Townend et al., 
2000). Ray and co-authors (2010) did find that heritability of dental fear was high in 
female twins and low in male twins. Though the development of dental anxiety in children 
does follow the three pathways of Rachman, the same cannot be said about dental 
phobia in children. The conditioning process either showed minimal or negative 
associations, meaning exposure may even act as a form of prophylaxis. The modelling 
pathway of developing dental phobia in children can be linked to the mothers anxiety and 
past experience, although in most studies it was noted that no direct observation was 
present (Townend et al., 2000). The information pathway, in which children either heard 
or saw “terrifying” events, can develop common phobias, however dental anxiety and 
dental phobia was not covered in the study (Ollendick and King 1991). Furthermore, it 
was reported that there is a strong relationship between dental fear and the dentist’s 
behaviour, which adolescents being nine times more likely to be very anxious if the 
dentist showed a lack of empathy (Townend et al., 2000). 
A systematic review by Zhou and colleagues (2011) reached a similar conclusion; giving 
specific instructions, showing empathy and giving a reassuring touch with verbal 
encouragement all discouraged dental anxiety and fear, while criticism for rebellious 
behaviour, coercion and restraining all had negative effects. Another factor thought to be 
involved in dental fear and anxiety is invasive and/or painful dental treatment, though 
most studies were retrospective in nature and inconsistent findings were reported in 
children. However, it was found that more check-ups prior to dental treatment may aid in 
the reduction of dental fear (ten Berge et al., 2002; Davey, 1989). This will aid in 
eliminating any uncertainty the child has, which plays a role in anxiety development.  
Furthermore, the appearance of the staff may trigger anxiety, especially when the child 
has a ‘white coat phobia’ (Fayle and Tahmassebi, 2003). Although anxious patients who 
avoid dental treatment due report more invasive treatment when compares to non-
anxious avoider, more of the former group seek treatment in the later stages of dental 
pathology, where severe pain is present (Liddell and Locker 2000).  Moreover, the 
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patient’s subjective perception of the dental visit was more important in the development 
of fear than the actual dental treatment (ten Berge et al., 2002). 
1.1.3 Dental Anxiety Effect and Outcome: 
It has been reported that children who are fearful of dental treatment avoid dental 
treatment, which generally has a detrimental effect on the carious dentition. If treatment 
is sought out, poor behaviour is exhibited. This has led to the development that dental 
anxiety is a predictor of dental caries; however, there are conflicting results (Taani et al., 
2005).  
Milgrom and co-authors (1995) divided the possible feared dental stimuli into three 
groups. These included highly invasive procedures, such as injections or drilling, 
victimisation, such as fearing strangers, and finally less invasive procedures, such as a 
dental exam. Fear of injections, namely blood injury injection phobia (BIIP) has been 
shown to overlap with dental anxiety. Vika and co-workers (2008) reported that 3.3% of 
18year olds avoid dental treatment when a dental injection is required. Moreover, 
children who have a fear of dentists not only have more carious teeth; they also have 
more teeth missing as a result of caries. Oral health is then perceived in a more negative 
fashion (Carillo-Diaz, et al., 2013b). The quality of life is reduced as a consequence of 
the dental phobia. This is thought to be due to the consequence of poor oral health status 
and the psychosocial effect of the phobia (Agdal et al., 2012). The quality of dental 
treatment performed is also affected, as a delay in seeking proper treatment due to 
dental anxiety often means that conservative dental treatment is not a feasible option 
(Newton et al., 2012). As proposed by Berggren and Meynert (1984), the dental anxiety 
cycle can be challenging to break; fear and anxiety will often lead to avoidance of care, 
which will worsen the present dentition leading to feelings of guilt and shame that will 
further increase fear and anxiety. 
1.1.4 Dental Anxiety in the UK: 
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Nuttall and co-authors (2008) reported that 75% of children in the UK have no anxiety at 
all and less than 4% of those interviewed had a phobia so severe that it affected their 
dental attendance. Moreover, the younger children in the study who were more anxious 
were inclined to have more active caries than those who were not anxious. Having 
extractions, whether under general or local anaesthesia, was shown to be linked to an 
increase in dental fear. Having restorative treatment did not seem to be associated with 
dental anxiety in the young, but in the 12 years and 15 years of age, anxiety was 
increased. 
1.1.5 Measures of Dental Anxiety: 
Dental anxiety can be assess by using various approaches, with questionnaires and 
rating scales being the more common method (Welbury et al, 2012). Behavioural 
assessments can also be performed as well to evaluate anxiety levels. In addition, 
anxiety can also be assessed through the use of psychometric scales by means of a 
questionnaire with categorical answer scales. Furthermore, a projective technique may 
be utilised by using a questionnaire with a continuous answer scale. Indirect measures 
such as measuring heart rate and palmar sweat index (PSI) have also been implemented 
to measure anxiety levels in children (Klingberg et al., 1995). The measuring tools should 
be quick, relevant for children and their dental experience and simple to analyse and 
score (Buchanan, 2005). The tool should also be valid in its measure of anxiety, which 
may be problematic for indirect measures involving physiological measures (Buchanan 
and Niven, 2002). As of yet, there has been no standardised method to evaluate dental 
anxiety; most methods involving questionnaires have not shown constant reproducibility 
and reliability, and physiological and observational scales are poorly developed (Welbury 
et al., 2012). 
1.1.5.1 Behavioural scales 
The use of patient administered questionnaires may not be suitable for children of young 
ages, as their understanding and vocabulary may not be well developed. In these cases, 
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behavioural scales may be used (Welbury et al., 2012). Frankl and co-authors (1962) 
originally developed the Frankl rating scale by measuring behaviour in five dental 
scenarios; parental separation, oral examination, prophylaxis, x-ray and departure from 
clinic. It is explained in the Table 1.1:  
Table 1.1 Frankl Rating Scale 
Category (symbol) Definition 
Definitely negative (--)  Refuses treatment 
 Forceful crying 
 Other evidence of severe 
negativity 
Negative (-)  Unwilling to accept treatment 
 Uncooperative 
 Some evidence of negative 
attitude that is not pronounced 
Positive (+)  Accepts treatment 
 Cautious at times, but willing to 
comply with dentist 
 Reserved at times, but follows 
dentist’s directions 
Definitely positive (++)  Good rapport with dentist 
 Shows interest in dental 
procedures 
 Shows signs of enjoyment and 
laughter 
 
The scoring of the behaviour has been conducted in various ways. An overall rating of 
the child’s behaviour is usually given, however, the sum of the individuals’ behaviour on 
certain occasions may provide a more accurate score (Dean et al., 2010; Aartman et al., 
1996) 
The Houpt scale scores behaviour on four distinct criteria, which include crying, 
cooperation, apprehension, and sleep. The dentist rates the child in five minute intervals. 
The score is then summed up and divided by the number of intervals. It can be a reliable 
tool, but should only be used to rate the patient’s response to specific aspects of dental 
treatment. The rating is described in the Table 1.2 (Hosey and Blinkhorn, 1995): 
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Table 1.2 Houpt Scoring criteria 
Criteria Scoring 
Crying 1. Screaming 
2. Continuous crying 
3. Mild and intermitted crying 
4. None  
Cooperation  1. Resists violently and disrupts treatment 
2. Treatment difficult due to excessive movement 
3. Minor and intermitted movement 
4. No movement 
Apprehension 1. Disobeys all instructions, hysterical 
2. Tremendously anxious, delays treatment and disobeys some 
instructions 
3. Mildly anxious and complies with support 
4. Follows instructions. Child is calm and relaxed 
Sleep  1. Fully awake 
2. Drowsy 
3. Sleeps intermittently 
4. Sound asleep 
Venham’s “Anxiety Rating Scale” and “Uncooperative Behaviour Rating Scale” (Venham 
et al., 1980) uses an ordinal scale from zero to five; “0” is relaxed, smiling and able to 
communicate with the dentist for the anxiety scale, and total cooperation for the 
behaviour scale, and “5” represents a child who is out of control in the anxiety scale and 
general protest in the behaviour scale. It was shown that the distance between each 
scale point was relatively equidistant (Venham et al., 1980). 
Other behavioural assessment tools include the visual analogue scale, a 100mm line 
where the rater marks the level of anxiety, and the global rating scale, where 1 is 
considered poor and 5 is rated as excellent (Hosey and Blinkhorn, 1995). 
1.1.5.2 Self-reported anxiety measure (Psychometric and 
Projective) 
Venham Picture Test (VPT): 
VPT consists of a series of eight pairs of pictures showing a male cartoon figure that was 
developed by Venham and Kremer (1979). Each frame depicts an anxious and non-
anxious child, with 1 point given every time the child selects the anxious male cartoon 
(Venham and Kramer, 1979). Aartman and co-authors (1997) stated that the reliability of 
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VPT has not been researched significantly, and requires further studying. Although the 
VPT can differentiate between fearful and non-fearful children, the correlation between 
VPT and other dental anxiety measures has been rated low to moderate (Porritt et al., 
2013; Aartman et al., 1997). Limitations of this method are related to the pictures; all of 
them illustrate a male character that may be difficult for young girls to relate to. Moreover, 
some of the pictures are vague in the emotion expressed (Buchanan and Niven, 2002). 
Facial Image Scale (FIS): 
The FIS consists of five “genderless” faces, ranging from very happy to very unhappy; 
the highest score was for the unhappy face. Children are told to select which face they 
feel represents them. It may be used as a measure by itself, or combined with other 
measures (Porritt et al., 2013). Although it has been shown to be correlated to VPT 
(Buchanan and Niven, 2002), the FIS has some limitations. The measure of anxiety is at 
a specific point during treatment and is not a state of anxiety. However, this measure is 
suitable for young children and those with limited cognitive development (Porritt et al., 
2013). 
Smiley Face Programme (SFP) and Smiley Face Programme – Revised 
(SFP-R): 
The SFP was developed by Buchanan (2005) and measures for items related to train 
dental anxiety; having a dental appointment the next day, sitting in the waiting room, 
about to have tooth drilled and about to receive dental injection.  The scale has seven 
faces for the child to choose from, with the fourth face being neutral. This measure is 
computerised, which makes it interactive for the child and assists in data collection, 
however, it is only limited to children who can understand how to use the computer. 
Moreover, the SFP is short and relevant to dental anxiety in children (Buchanan, 2005). 
Buchanan later modified the SFP, adding an item to assess anxiety with extractions, 
updating the pictures and amending the instructions, making it more suitable for younger 
children. The SFP was found to be suitable for children as young as 6 years of age, while 
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the SFP-R was suitable for children as young as 4 years of age (Buchanan, 2010; 
Buchanan 2005). 
Children’s Fear Survey Schedule – Dental subset (CFSS-DS), and Dental 
Fear Survey Schedule – Short Form (DFSS-SF): 
The CFSS-DS is a commonly used anxiety measuring tool with high reliability (correlation 
coefficient ranging from 0.82-0.9). Validity, on the other hand, was variable with results 
showing moderate to good validity. The scale is often used when large groups are 
involved (Klingberg and Broberg, 2007; Aartman et al., 1997).  It consists of 15 scenarios 
that are scored on a five point scale with a score of 1 denoting no fear and a score of 5 
denoting very frightened. The various scenarios are categorised into three different 
groups, which are invasive procedures, potential victimisation and non-invasive dental 
procedures (Porritt et al., 2013; Buchanan, 2005). Cut-off readings are variable 
depending on the study. Klingberg and Broberg (2007) reported cut-off values for fearful 
ranging from 37-42, while Porritt and co-authors (2013) reported scores above 32 as 
anxious and scores greater that 38-39 as very anxious. The CFSS-DS, however, fails to 
address certain factors related to dental anxiety; these include the child’s physical 
response, behaviour and thoughts. Additionally, the questionnaire has a few unrelated 
questions, such as having treatment carried out in a hospital, and is also quite time 
consuming. An eight itemed dental survey that scored in a similar fashion, the DFSS-SF, 
was then developed. However, the limitations of the CFSS-DS are still apparent in the 
DFSS-SF (Porritt et al., 2013; Buchanan, 2005). 
Dental Anxiety Scale (DAS) and Modified Dental Anxiety Scale (MDAS): 
The DAS was initially developed by Corah (1969). It comprises of four questions scored 
from one to five with a higher score being more anxious. The questions were regarding 
the following topics:  
 Anticipating going to the dentist the following day 
 Anticipating  the appointment while seated in the waiting room 
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 Anticipating the dentist working on your teeth while seated in the dental chair and 
the dentist is preparing the drill 
 Anticipating the dentist cleaning your teeth while seated in the dental chair and 
the dentist is preparing the instruments to “scrape your teeth around the gums 
The cut-off score for an anxious patient ranged from 12-16, with the upper quartile being 
selected in studies on adults (Aartman et al., 1997). Additionally, it can also be combined 
with the FIS. Although validity was high, this scale was largely used on an adult 
population. Furthermore, it neglects to assess anxiety related to local and general 
anaesthesia, and inhalation sedation (Humphris et al., 1998). Since the DAS was 
developed namely for use in the adult population, the design of the DAS may not be 
suitable with children (Porritt et al., 2013). 
The MDAS was developed to tackle some short-comings with the DAS by Humphris and 
colleagues (1995). With the DAS, the answers for all the questions were not 
standardised. The answers also included symptoms that may not be experienced by all 
subjects answering the questionnaire. They therefore changed all the answers from not 
anxious to extremely anxious. A fifth item concerning local anaesthetic injection was 
added. A cut-off of 19 out of a possible 25 for dental phobia is used with this scale 
(Humphris et al., 1995). 
Although the MDAS did address some of the issues with the DAS, it was still developed 
using adult subjects, hence an eight items questionnaire entitled the Modified Child 
Dental Scale (MCDAS) was developed by Humphris and co-authors (1998). The 
questions and answers were amended and an additional three more questions were 
added. The scoring was from relaxed and not worried (1) to very worried (5). The 
questions were focused on the child’s feeling towards (Humphris et al., 1998): 
 Generally going to the dentist 
 Your teeth being looked at 
 Your teeth being scraped and polished 
 An injection in your gums 
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 A filling being done on your teeth 
 Your tooth being taken out 
 Being put to sleep for the treatment 
 A “gas-air” mixture is given to you that will make you feel comfortable, but will not 
make you sleep for treatment 
Howard and Freeman (2007) further modified the MCDAS by adding 5 faces (MCDAS-
f) and found that it was suitable for children as young as 5 years of age, while the MCDAS 
was for children aged 8 years and older (Buchanan, 2010; Howard and Freeman, 2007). 
Indirect analysis of anxiety: 
Indirect analysis of anxiety involves measuring physiological responses to anxiety and 
requires specialised equipment (Klingberg et al., 1995). The assumption made was that 
although physiological measures are direct measures of anxiety, any increase in arousal 
during dental treatment was linked to stress and anxiety with the dental visit. However, 
Venham and Quatrocelli (1977) found that changes in heart rate were not associated 
with anxiety. Another studied physiological response is the palmar sweat index. Lore 
(1966) stated that emotional sweat areas vary from the heat regulatory area, with the 
emotional areas being the palm of the hands, soles of the feet, armpits, groin, forehead 
and the upper lip. He concluded that anxiety was associated with increased sweating 
when using the first three fingers to measure the palmar sweat index. 
1.2 Sedation 
Anxiety control involves using various behaviour management techniques, both 
pharmacological and non-pharmacological. For children who are cooperative or 
potentially cooperative, non-pharmacological methods of behaviour management may 
be a suitable method of anxiety control; however, pre-cooperative and uncooperative 
children may require conscious sedation or general anaesthesia (GA) (Welbury et al., 
2012). Nonetheless, the decision for which method of anxiety control is to be used should 
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be made on a patient and treatment specific basis (Scottish Dental Clinical Effectiveness 
Programme (SDCEP), 2012). Factors that are considered are: 
 Age of the patient 
 Degree of surgical trauma and treatment complexity 
 Anxiety level of the patient 
 Response to previous sedation or expected response to sedation 
 Medical status, as per the ASA classification (American Society of 
Anesthesiologists, 2006) 
After the publication of ‘A Conscious Decision’ (Department of Health, 2000), it was 
recommended that the use of GA for dental treatment should only be carried out in 
hospital settings, and only when all other alternatives, such as sedation, have been 
exhausted.  However, when sedation is to be considered, it should be used as an adjunct 
to behaviour management techniques, and all pharmacological and non-
pharmacological methods should be considered when treatment planning each 
individual case (SDCEP, 2012; Welbury et al., 2012).   
The aims of using sedation in children during treatment are to assist in reducing fear and 
anxiety, and to enhance pain control. It also reduced the movement of the child during 
treatment (National Institute for Health and Care Excellence (NICE), 2010). Sedation 
also prevents deal fear from developing when used on children “prophylactically” in 
situations that may possibly be traumatic. Furthermore, it supports the dentist by 
facilitating the completion of the treatment. The stress and unpleasant emotions 
experienced by the dentist will also be reduced, in addition to preventing burn-out 
(Welbury et al., 2012; European Academy of Paediatric Dentistry (EAPD), 2003). 
The American Society of Anesthesiologists (ASA) (2009) stated that sedation was a 
continuum of four stages, and it was difficult to calculate how the patient would respond 
to sedation. The practitioner should be capable of rescuing the patient from a level of 
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sedation deeper than the level of sedation used. Descriptions of these stages are 
presented in Table 1.3: 
Table 1.3: Stages of sedation 
Stage of sedation Definition  
Minimal sedation – Anxiolysis  Drug induced state 
 Patient responds to verbal command 
 Cognitive function and coordination 
impaired 
 Protective reflexes and cardiovascular 
function maintained 
Moderate sedation – 
Conscious sedation 
 Drug induced decrease in consciousness 
 Patient responds purposefully to verbal 
commands and/or light tactile stimuli 
 Respiration, airway and cardiovascular 
functions maintained 
Deep sedation  Drug induced decrease in consciousness 
 Patient not easily aroused, but can 
respond purposefully 
 Airway and breathing impaired, but 
cardiovascular functions usually 
maintained 
General anaesthesia  Drug induced loss of consciousness 
 Patient cannot be aroused 
 Airway and breathing needs to me 
maintained with positive pressure 
ventilation 
 Cardiovascular function impaired 
 
Another term used in sedation is ‘dissociative sedation’, which is defined as a trance-like 
condition that is brought upon by ketamine. Protective reflexes are maintained along with 
spontaneous breathing and cardiopulmonary functions (Kraus and Green, 2006). 
 
1.2.1 Classification of Sedative Drugs: 
 
Sedative hypnotics are commonly used for procedural sedations. They include 
benzodiazepines, barbiturate, propofol and chloral hydrate. Due to the lack of analgesia 
produced with the drugs in this category, opioids are occasionally added for painful 
procedures. Inhalation sedation, whether alone or combined with local anaesthesia, and 
dissociative sedation are gaining popularity (Kraus and Green, 2006). 
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1.2.2 General Indications for Sedation 
Sedation in children is indicated when procedures are too frightening or painful, or if the 
child is ill, in pain or has behavioural issues. The cost-effectiveness of sedation or 
treatment under local anaesthetic should also be considered (NICE, 2010). Deep 
sedation and the use of multiple drugs to induce sedation in anxious children are not 
recommended in the dental setting (Welbury et al., 2012; Hosey, 2002).  
1.2.3 Conscious Sedation 
The Standing Dental Advisory Committee (2003) defined conscious sedation as  a 
technique involving the use of a drug or multiple drugs to induce a state of CNS 
depression in which dental treatment can then be carried out. Furthermore, the drugs 
used should have a large enough safety margin to avoid loss of consciousness. It is 
critical that verbal communication is always maintained; however, in cases of special 
needs where verbal communication may be lacking, then the usual method of 
communication for the patient should be maintained (SDCEP, 2012; Standing Dental 
Advisory Committee, 2003). 
Various methods are used in sedation, however a systematic review conducted by 
Matharu and Ashley (2005) stated that due to the poor quality of research and the wide 
variety of methods used, they were unable to determined which single method was most 
ideal. The method can be classified as standard or alternative sedative techniques 
(Standing Committee on Sedation for Dentistry, 2007):  
 Standard techniques being nitrous oxide/oxygen inhalation sedation alone, IV 
midazolam alone, and oral and transmucosal benzodiazepine  
 Alternative techniques being inhalation sedation other than nitrous oxide/oxygen, 
combination of sedative agents or routes of administration, propofol either alone 
or in combination, and any form of conscious sedations in patients younger than 
12 years of age, excluding nitrous oxide/oxygen inhalation sedation. 
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The primary route of administration for sedation in children is inhalation, followed then 
by IV, which should only be used in cases when inhalation sedation may not be 
successful (Wilson, 2013). Other routes of administration include oral, transmucosal, and 
intramuscular. These methods may be less invasive and more convenient for the child, 
but they are also non-titratable, hence the depth of sedation cannot be effectively 
measured (Kraus and Green, 2006). Oral and transmucosal administration of sedative 
agents should only be reserved for cases where titratable techniques cannot be used as 
the control of the depth of sedation is low (SDCEP, 2012). Other indications include 
difficulty with cannulation due to phobias, learning difficulties, or other disabilities, and 
anxiety levels too high for Nitrous oxide/ Oxygen inhalation. However, difficulty due to 
anatomical variations is a contraindication to oral and transmucosal sedation (Standing 
Committee on Sedation for Dentistry, 2007).  
1.2.3.1 Indications and contraindications of conscious sedation 
Conscious sedation can be used in cases of dental anxiety and phobia. It is also indicated 
when dental treatment is expected to be prolonged or traumatic. Certain medical 
conditions may impair the child’s ability to cooperate, or may possibly be exacerbated 
with the added stress of the dental treatment; in these cases, conscious sedation is 
indicated. Furthermore, conscious sedation is indicated for children with special needs 
(SDCEP, 2012). Treatment need, and the complexity of the treatment should also be a 
considered when discussing the need of conscious sedation. For children with an ASA 
classification of I or II, conscious sedation can be performed in the community or 
specialty centres, however, children classified as ASA III or higher must have the 
sedation conducted in a hospital setting.  Moreover, contraindications for the use of 
conscious sedation include children, below the age of one year and expectiant mothers 
in their first trimester (EAPD, 2003; Hosey, 2002).  
1.2.3.2 Inhalation sedation 
Nitrous Oxide 
  
- 19 - 
Inhalation sedation using nitrous oxide/oxygen mixture is the recommended method of 
sedation for children in the United Kingdom, with 83-96% of children successfully 
completing treatment (Soldani et al., 2010).   The objectives of nitrous oxide/oxygen 
inhalation are to reduce fear and pain, and to improve patient behaviour and cooperation 
(Roberts, 1990a). There are three components in the use of inhalation sedation that are 
essential to improve success; administration of low to moderate concentrations of nitrous 
oxide that is titrated on an individual basis, comforting and semi-hypnotic cues, and 
proper equipment with fail safes and regular maintenance, including the use of 
scavenging systems (Kraus and Green, 2006; Roberts, 1990a). Nitrous oxide is an 
odourless and colourless gas that has a relatively quick onset, with in 1 minute, and 
recovery once stopped, due to its low solubility (Kraus and Green, 2006; Paterson and 
Tahmassebi, 2003). The concentration of nitrous oxide used varies from 30-70% with 
the remaining being oxygen, and depending on the amount used, different planes of 
sedation can be reached (Kraus and Green, 2006; Roberts, 1990a): 
Table 1.4: Planes of Sedation with Nitrous oxide/Oxygen inhalation 
Plan Definition  
Moderate 
sedation and 
analgesia 
 Concentration of Nitrous oxide used : 5-25% 
 Patient may feel tingling in toes, fingers, oral cavity, back, 
hand and chest 
 Patient is relax, with an increase in pain threshold and a 
decrease in anxiety and fear. Patient still responsive 
 No side effects but hearing, vision, touch and 
proprioception impaired 
Dissociative 
sedation and 
analgesia 
(psychosedation) 
 Concentration of Nitrous oxide used: 20-55% 
 Patient may feel a sense of euphoria and detachment 
from the environment. Feeling of warmth, buzzing in ear, 
drowsiness and light headedness may be common 
 Patients responsiveness may be delayed 
 Nausea and vomiting possible but rare. Amnesia 
possible 
Total Analgesia  Concentration of Nitrous oxide used: 50-70% 
 Patients more likely to dream 
 Loss of ability to maintain mouth open and to respond to 
commands 
 Loss of consciousness possible 
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The planes of sedation for nitrous oxide/oxygen mixture are described above (Table 1.4). 
Due to the low solubility of nitrous oxide, accidental overdose is possible, and it is crucial 
to note signs and symptoms of over-sedation (Roberts, 1990a). These include an inability 
to maintain an open mouth, respond to the dentist and increase in movement, heart rate, 
blood pressure, respiration rate and sweating; the use of a mouth probe during inhalation 
sedation will make identifying mouth closure more difficult (Paterson and Tahmassebi, 
2006; Roberts 1990b). Moreover, the patient may experience acute hearing, sleepiness, 
and visual impairment (Paterson and Tahmassebi, 2006). If over-sedation has occurred, 
the nitrous oxide concentration should be reduced by 10-15% increments; however, if no 
changes are visible, nitrous oxide should be stopped and 100% oxygen given. It is 
essential that after completing treatment with nitrous oxide/oxygen inhalation sedation,  
the patient should receive 100% oxygen for 3-5 minutes, followed by a period of 
ambience are to ensure there is complete elimination of nitrous oxide (Paterson and 
Tahmassebi, 2006; Roberts 1990a). 
Although no serious morbidity has been reported (Soldani et al., 2010; Roberts 1990a), 
side effects can occur. These are more common when moderate or deep levels of 
sedation have been used; adverse effects include emesis (1-10% of patients), nausea 
and dizziness with emesis being more common with the use of fluctuating levels of 
nitrous oxide and oxygen, higher concentrations of nitrous oxide and lengthy 
appointments (Kraus and Green, 2006; Paterson and Tahmassebi, 2003). Other serious 
side-effects include diffusion hypoxia and bone marrow suppression; however, with the 
administration of 100% oxygen after the appointments and the short duration of dental 
appointments, the likelihood of these events occurring are minimal (Paterson and 
Tahmassebi, 2003). Moreover, a systemic review conducted by Faddy and Garlick 
(2005) shown no statistical significant of minor adverse effects from arising, with serious 
adverse effects, like oxygen desaturation and hypotension cannot be solely attributed to 
nitrous oxide/oxygen inhalation sedation. 
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Dentists and auxiliary staff members who are exposed to excessive amount of nitrous 
oxide can also suffer from adverse effects such as haematological disorders, such as 
pernicious anaemia and reproductive disorders, such as decrease in fertility and 
spontaneous abortion (Paterson and Tahmassebi, 2003).  The published literature 
showed weak to moderate association, with most studies carried out before the use of a 
scavenging system was required (Rowland et al., 1995). Rowland and co-authors (1995) 
found that when using a scavenging system, there was no increased risk of spontaneous 
abortion in comparison to the unexposed group; 6.5% and 6.7% reported spontaneous 
abortion respectively with 10.2% reporting spontaneous abortion in the group working 
with no scavenging systems. Although genetic damage due to nitrous oxide exposure 
sedation was reported by Hoerauf and co-authors (1999), they stated that healthy 
individuals would have the capabilities to repair the genetic damage. 
Indications and Contraindications of Nitrous Oxide/Oxygen Inhalation Sedation 
The primary goals for the use of inhalation sedation using nitrous oxide/oxygen mixture 
is to manage medically compromised patients, reduce anxiety and fear and control 
gagging to levels where treatment can safely be carried out (Malamed, 2010; Paterson 
and Tahmassebi 2003; Robert, 1990b). Though most contraindications for nitrous oxide 
inhalation sedation are relative and not absolute, the risk of using nitrous oxide inhalation 
sedation should be balanced with the risks associated with GA; however, all cases 
should be assessed on an individual bases. Nevertheless, most adverse risks may be 
avoided when using oxygen concentrations greater than 20% of the inhaled mixture 
(Malamed, 2010; Paterson and Tahmassebi 2003). Below is Table 1.5 explaining the 
indications and contraindications for the use of nitrous oxide/oxygen inhalation sedation:
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Table 1.5: Indications and Contraindications of Inhalation Sedation 
Indication  Contra-indication 
Mild to moderate fear and anxiety related 
to dental treatment 
 
Claustrophobia; anxiety level may be 
increased when attempting to place the 
mask 
Mouth breathers 
Acute dental problems where profound 
local anaesthesia cannot be achieved 
(acute pulpitis) and treatment of 
hypersensitive teeth 
Myaesthaenia gravis and multiple 
sclerosis; muscle activity depressed, and 
using sedation may further depress 
muscle activity 
Cardiovascular disease (angina, ischemic 
heart disease); high oxygen concentration 
reduces risk of ischemic attack 
Children with behaviour problems; pre-
cooperative and non-cooperative children 
may not breath through their nose and 
excessive crying will limited inhaled 
nitrous oxide 
Respiratory disease (asthma); anxiety is 
reduced and non-irritating vapour is used 
hence reducing risk of asthmatic attack 
Chronic obstructive pulmonary disease; 
increase concentrations of oxygen may 
lead to apnea as low concentrations of 
oxygen is the stimulus to breath  
Dental treatment will be traumatic to the 
patient 
Psychological disorders (compulsive 
personality and personality disorders); 
patients may resist the effects of sedation 
Pregnancy; only after 1st trimester if 
needed 
Pregnancy; best avoided during 1st 
trimester and may need to delay 
treatment in 3rd trimester. 
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Cerebrovascular disease as the risk of a 
hypoxic episode is low 
Epilepsy; anxiety and hypoxia reduced, 
both triggers for seizures  
Upper respiratory tract infection and acute 
respiratory problems; inability to breathe 
through  the nose and chance of possible 
cross contamination 
Hepatic and renal disease; no 
biotransformation in the body 
Diseases of closed spaces (bladder, ear 
infection, pneumothorax 
Medically compromised patient where 
risks involved with GA is too great 
Inability to communicate 
Learning difficulties 
Cerebral palsy; can control movements Patients with head injury; intracranial 
pressure is increased with nitrous oxide 
Sickle cell disease; high oxygen 
concentration reduces risk of sickle crisis 
Hypovolemia; loss of consciousness may 
occur faster 
Adapted from Malamed, 2010; Kraus and Green 2006; Faddy and Garlick, 2005; Paterson and Tahmassebi, 
2003 Hosey, 2002; Roberts, 1990b 
Advantages and Disadvantages of Nitrous Oxide/Oxygen Inhalation Sedation 
Nitrous oxide sedation can be used in a variety of patients including children, adults and 
those with special needs with minimal risk of adverse reactions, due to the large safety 
margin (Kraus and green, 2006; Roberts 1990a). Due to its low solubility, it can rapidly 
cross the alveolar arterial membrane, hence providing a rapid onset and recovery. It also 
has an anxiolytic and analgesic effect; significant analgesic effect is seen when nitrous 
oxide concentrations are 50% or more (Faddy and Garlick 2005). Furthermore, due to 
CNS depression, it can lead to amnesia although it is somewhat variable. However, 
concentration and intelligence may also be affected (Paterson and Tahmassebi, 2003). 
Additional advantages and disadvantages are summarised below (Malamed, 2010; 
Paterson and Tahmassebi, 2003): 
 Advantages: 
o Non-invasive and no needles are needed 
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o Easily titratable 
o Protective reflexes are maintained 
 Disadvantages: 
o Not potent 
o Requires the patient to receive psychological reassurance by the dentist 
o Continuous flow needed 
o Nasal hood may interfere with treatment and seal may be broken; nasal 
hood requires the patient to breathe through their nose and it may be 
rejected 
o Nitrous oxide pollution; unscavenged nitrous oxide can have negative 
effects to staff and patients 
o The initial cost of equipment needed is quite high, and also requires 
regular maintenance  
Sevoflurane  
Sevoflurane is a sweet smelling and volatile gas which is used in GA, but has also been 
used as a form of conscious sedation with concentrations ranging from 0.1%-0.3%. It 
can also be combined with 40% nitrous oxide and the remainder being oxygen. The 
concentration used may vary from patient to patient and also from appointment to 
appointment (Soldani et al., 2010; Girdler et al., 2009). Lahoud and Averley (2002) found 
that when using concentrations of 0.1-0.3% sevoflurane with 40% nitrous oxide, can be 
more effective than nitrous oxide sedation alone; however, more training and additional 
cost are required. They concluded that when nitrous oxide alone fails, sevoflurane can 
be added in order to reduce the need of GA. Other agents such as halothane and 
isoflurane are too potent to be used in sedation, and further research is needed to assess 
their practicality in paediatric dentistry (Girdler et al., 2009; Hosey, 2002) 
1.2.3.3 Oral sedation 
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The intra-oral route of sedation is one of the most convenient methods; no injections are 
required and less patient cooperation is needed when compared to inhalation sedation 
(Malamed, 2010: Girdler et al., 2009). However, due to the first pass effect, it is not as 
reliable. Oral sedation is an acceptable technique for pain and anxiety management. In 
order to effectively provide such a service, the operator should be trained in airway 
management, and should also be able to rescue the patient from a deeper level of 
sedation. Administration of the sedative agent should be performed in clinic where a 
suitable member of staff can monitor the patient, and not at home prior to the 
appointment; this will ensure that the correct dose is given (Malamed, 2010).  
Oral Sedative Agents  
Various agents have been used as oral sedatives. However, prior to sedation, a complete 
medical history, age, weight, and list of medications the patient is taking must be noted. 
Furthermore, the degree of anxiety and level of sedation required by the dentist must 
also be assessed. Although titration may not be possible during the appointment, 
‘titration by the appointment’ can be done; the efficacy of sedation at the first appointment 
is assessed, following which the dose for the next appointment can be adjusted as 
needed (Malamed, 2010). 
The properties of an ideal oral sedative are mentioned below (Girdler et al., 2009): 
 Alleviate fear and anxiety 
 Maintain protective reflexes 
 Easily administered  
 Free from any adverse effects 
 Predictable durations and onset 
 Quickly metabolised and excreted 
 No active metabolites 
The predictability of the sedative is dependent on the degree of anxiety, rate of 
absorption and the rate of metabolism of the patient. Absorption can be quite variable 
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from patient to patient and also within the patient’s own biological factors (Table 1.6). 
The type of agent used can also play a role in the absorption rate. (Malamed, 2010: 
Girdler et al., 2009). 
Table 1.6: Factors affecting absorption (Malamed, 2010: Girdler et al., 2009) 
Drug Related Factors Patient Related Factors 
Lipid solubility of the drug; increase in 
lipid solubility results in increased 
absorption  
pH of gastric fluid; acidity of stomach and 
small intestines can lead to drug 
deactivation 
Dosage Form; aqueous solutions more 
readily absorbed than Tablets or oily 
solutions 
Gastric emptying; time increases if fat 
content in stomach is high. 
Recommended to take any oral 
medicament with water 
Size of drug particle; smaller the particles, 
greater the absorption 
Surface area of mucosa; small intestine 
has larger surface area, hence more 
absorption occurs in duodenum than in 
the stomach 
Drug acidity; organic acids freely diffuse 
across gastric mucosa, where drugs that 
are bases poorly absorbed 
Hepatic 1st pass effect; drugs absorbed 
from GI pass through the hepatic portal 
system, which can inactive the drugs 
 
Midazolam 
Dosages 
Midazolam can be given as an elixir or mixed with juices. Orally, the onset is 20-30 
minutes; timing of onset and recovery may vary depending on first pass effect. In all 
cases where oral midazolam is used, a cannula should be placed to allow for reversal 
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with Flumazenil in cases of emergencies; however, it should be noted that rapid reversal 
may lead to sympathetic nervous system stimulation, while a titrated reversal may lead 
to only partial stimulation (Girdler et al., 2009; Kraus and Green, 2006). It should be 
noted that midazolam is not licensed as a sedative agent in children in the UK. Moreover, 
it should only be used in a hospital setting and under supervision of a qualified seditionist 
(Standing Committee on Sedation for Dentistry, 2007; SIGN, 2004). 
The dosage used varies from country to country but ranges from 0.3-0.75mg/kg., with a 
maximum dose of 12mg. Tablets should be taken 1 hour before the appointment, while 
oral suspensions should be given 20-30 minute before their appointment, The peak 
concentration in plasma is reached in 20 minutes, and onset is within 45 minutes. It is 
eliminated from the system within 2 hours (Day et al., 2006; EAPD, 2003). The oral dose 
is higher than the IV dose as midazolam becomes inactivated from the 1st pass effect 
(Welbury et al., 2012). 
Midazolam is contraindicated in children under 1 year old, and in those suffering acute 
illnesses, neuromuscular diseases, allergies, sleep apnoea, and hepatic dysfunction 
(EAPD, 2003). 
Effect and Biochemical properties 
The most commonly used oral sedative is midazolam. It is a lipophilic agent which 
exhibits anterograde amnesia, sedative, hypnotic, anxiolytic, anticonvulsant and muscle 
relaxing properties; however, they do not have any analgesic properties (Kraus and 
Green, 2006; EAPD, 2003). Midazolam is classified as a short acting benzodiazepine. 
Oral administration does not need much cooperation from the patient. The main concern 
with oral midazolam and other oral sedatives is that they cannot be titrated; this can lead 
to either over-sedation or under sedation, therefore patient assessment prior to sedation 
is important (Day et al., 2006; Kraus and Green, 2006). Midazolam may lead to cardiac 
depression although the risk is low when Midazolam is titrated in IV sedation. The risk of 
hypoxia and respiratory depression is higher when using benzodiazepines. As published 
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by the SDCEP (2012) there is a high level of evidence to suggest that oral midazolam is 
safe and effective; however, it is less controllable and less predictable than IV sedation 
(SDCEP, 2012; Kraus and Green, 2006). A rare complication that has been reported in 
a few children treated under oral midazolam is ‘disinhibitory behaviour’. The child patient 
may be crying, combative, disoriented, agitated and restless (Day et al., 2006; Kraus and 
Green 2006). 
Guidance 
Appropriate training is needed to understand drug interactions, airway management and 
basic life support (Lourenço-Matharu and Roberts, 2010; Dionne et al., 2006). Dionne 
and co-authors (2006) published a list of ‘Safety Considerations for use of Dental 
Organisation for Conscious Sedation’s Protocol’; however, their conscious sedation 
protocol is for the use of oral triazolam. They recommended that only adults and patients 
who are ASA classification I or II should be sedated with triazolam. Moreover, a full 
medical and drug history is needed. Furthermore, at least 18 hours of didactic training 
with at least 20 clinically oriented experiences with patients is required by the American 
Dental Association prior to conducting oral sedation. In the UK however, in order to be 
considered competent in sedative techniques for children, the dental practitioner should 
have completed at least 100 cases. Additionally, four years of post-registration 
experience and training is needed in paediatric cardio-pulmonary resuscitation 
(Lourenço-Matharu and Roberts, 2010). Appropriate equipment is needed to effectively 
monitor the patient. These include the use of a pulse oximeter and automatic blood 
pressure monitor which measures at 5 minute intervals. Moreover a portable positive 
pressure oxygen delivery system should also be available. Finally there should be a 
proper emergency protocol to deal with medical emergencies along with a suitable 
emergency kit, including flumazenil in cases where reversal may be needed (Dionne et 
al., 2006). As recommended by SDCEP (2012), pulse oximetry and blood pressure 
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monitoring is required when oral sedation is used; furthermore, the sedationist should be 
trained in other titratable methods of sedation and in venous cannulation. 
Other Sedative Agents 
Although midazolam is the most commonly used oral sedative, other agents can also be 
used and are mentioned in Table 1.7.
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Table 1.7: Oral Sedatives 
Drug Dose Onset and 
Duration 
Effects Other relevant Information 
Chloral Hydrate -500mg/5ml 30-45 min before appointment. 
-If failure to achieve desired level of sedation with 1 dose, don't 
give further dose or other medication 
Onset: 15-30min 
Duration: 1-2hrs 
GI Upset 
Can have an anxiolytic effect 
-Fasting 2hrs prior 
- Bad taste. Diluted with water, juice acetaminophen 
-Never add to alcohol 
-Titrate by appointment 
-Effective for very young children or special needs 
-Possible risk of carcinogenicity 
Hydroxyzine Hydrochloride 10mg/5ml (syrup) 
Pamoate  25mg/5ml (oral suspension 
Apprehensive  50mg 2hr and 1hr before 
Less apprehensive single dose 50mg-75mg 1 hr before 
Aggitated  25mg 3x daily day before then same as above 
Divided dose: 25mg night before, 25 mg morning of, and 25 mg 
1hr before appointment 
Onset: 30-60 min 
Duration: 1-2 hrs 
Dry mouth, fever, skin rash 
Minimal respiratory and cardiac depression 
Hydroxyzine hydrochloride can have an antiemetic and 
antispasmodic effect 
-Children older than 3 
-Can be combined with nitrous oxide but reduce the doses 
-Should be noted that polypharmacy is not recommended in the UK 
Promethazine Tablet or syrup -1mg/kg Often given in 
combination with 
other agents 
Often given in combination with other agents -Combined with other drugs 
-Sole agent not recommended for severe apprehension 
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Diazepam 
(Valium) 
Pill or suspension 
Dosage: 0.2-0.5mg/kg: 
4-6yrs  2-5mg 3x before treatment with last dose 1hr before 
+6yrs  5-10mg 3x before treatment with last dose 1hr before 
OR 
-Single dose 1 hr before 
-1/2 dose night before and ½ dose 1hr before 
Onset: 1hr 
Duration: 2hrs 
Half-life: 24-48 
hrs 
Wide margin of safety 
Anterograde amnesia 
Similar side effects to Midazolam 
-Used for hyperactive, highly anxious and excitable kids aged 4 yrs. or older 
-Effective in management of pre-op anxiety 
-Oral benzodiazepine unpredictable in kids 
Ketamine 3-6mg/kg Onset: 20min 
Duration: 35min 
Hypertension, hallucinations, physical movements, 
increase salivation, increase risk of laryngospasm 
Cal have an amnesiac and analgesic effect 
-Used for dissociative sedation 
-Fast acting 
-Wide safety margin 
Adapted from Welbury et al., 2012; Malamed, 2010; EAPD, 2003; Hosey, 2002; Alfonzo-Echeverri et al., 1993; Badalaty et al., 1990 
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Dosages of any oral sedative agents are highly dependent on the weight of the child. It 
should be noted that the child may require 1-hour supervision post-operatively when in 
recovery to assess for any side-effects (Welbury et al., 2012). Although in the United 
Kingdom, oral sedation only involves the use of a single sedative agent, commonly 
midazolam, in other institutions polypharmacy may be practiced with the prescription of 
various combinations of oral sedatives. It should be noted that in the United States, there 
is no consensus on the dosages of agents that are used in combination therapy (SDCEP, 
2012; Chowdhury and Vargas, 2005). 
Indications and contraindications 
According to the BDA guidance on conscious sedation (2011), all titratable forms of 
sedation should be exhausted. Oral midazolam in indicated in children who are classified 
as pre-cooperative and also in special needs cases; however, oral midazolam is 
contraindicated in cases of hypersensitivity to the sedative agent, morbid obesity, airway 
obstruction and sleep apnoea (Meechan et al., 1998). 
Advantages and disadvantages  
The advantage and disadvantages are summarised in Table 1.8 (Meechan et al., 1998) 
Table 1.8: Advantages and Disadvantages of Oral Sedation 
Advantages Disadvantages 
 Cheap and non-invasive 
 Ease of administration 
 Low risk of adverse reactions 
 
 Compliance is still needed 
 Variable onset and absorption 
 Not titratable hence cannot alter sedation 
depth 
 Short duration of action 
Adapted from Meechan et al., 1998 
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Literature on various oral sedative agents 
Chowdhury and Vargas (2005) conducted a retrospective study comparing a 
combination of chloral hydrate, meperidine and hydroxyzine to oral midazolam in 
paediatric dental patients; both groups were also given 50% nitrous oxide / oxygen 
inhalation sedation. Success was based on level of movement, cooperation, use of 
restraints and whether treatment was completed. They reported that the combination 
therapy had a significantly higher success rate than midazolam with children being three 
times more likely to complete treatment when the combination therapy was used. Oral 
midazolam was found to be 70% successful whereas the combination therapy was 90% 
successful. There was no significant difference reported between heart rate and 
desaturation with the type of drug regimen used. 
Another study conducted by Avalos-Arenas and co-authors (1998) looked at whether 
adding hydroxyzine to chloral hydrate affected the behavioural and sedative response of 
the paediatric patient in a randomised double blinded study. They reported that the 
overall behaviour of the child did not differ in either the choral hydrate only or when 
combined with hydroxyzine; however, a deeper level of sedation and higher rates of 
desaturation were reported in the combination group. 
Fraone and co-authors (1999) assessed the effect of oral midazolam on three age 
groups; 24-35 months, 26-47 months, and 47-59 months. The Ohio State behaviour 
rating scale was used to assess behaviour and the heart rate, oxygen desaturation and 
blood pressure were measured as physiological parameters. They reported no statistical 
significant difference in the behaviour across the age groups. Moreover, no significant 
effects on physiology were reported.  Their study concluded that oral midazolam could 
promote ‘quiet behaviour’ in up to 49% of cases within the age range studied. 
In a study comparing oral midazolam with inhalation sedation using nitrous oxide/ oxygen 
gas mixture for extractions of primary teeth in an older age group (5-10 years) Wilson 
and co-authors (2006) found that oral midazolam is as safe and effective as nitrous oxide 
sedation. Although Midazolam was found to be acceptable in 59% of children and 
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preferred in 36% of children, nitrous oxide sedation was rated as more acceptable and 
also more preferred option of sedation (Wilson et al., 2006). However, the flaw in the 
study was in its design; as a crossover study, this may lead to a carryover effect. 
Additionally the sample size was small which may have had a serious effect on the 
precision of the study. A review of the literature published by NICE (2010) showed that 
although there was a moderate quality of evidence showing that oral midazolam has a 
shorter induction, recovery, and total time, there was no significant difference in 
procedural time and patient preference when data was pooled; the data from Wilson et 
al., (2006) was not available and hence not included in the meta-analysis conducted 
(NICE, 2010).  
1.2.3.3 Intravenous sedation 
Intravenous sedation is only recommended in a few cases and should not be used for 
pre-cooperative children. The current policy in the UK is that IV sedation should only be 
used for children aged 16 years and above. The recommended method is the use of a 
titrated dose of a single drug; often midazolam is used for adolescents who are both 
emotionally and psychologically stable (SIGN, 2004; Hosey, 2002). Fixed and bolus 
doses are not acceptable methods of administration as they are not titratable. However, 
continuous infusion of drugs, either as a single dose or in combination may be justified 
in some cases; the experience level of the practitioner, the training level of the sedation 
team and the facilities available have to be all taken into consideration (Standing Dental 
Advisory Committee, 2003). 
Administration and Monitoring:  
Prior to administering the IV agent, a pre-operative assessment must be conducted to 
assess the suitability of the patient. Additionally, proper fasting instructions can be given 
and informed consent gained. A full medical history, including all the medications that 
the patient is taking must be recorded (Malamed, 2010).   
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A secure IV access is needed, not only for administering the sedative drug but also 
administering the reversal agent; the cannula should be kept till recovery. Sites for the 
cannula include either the dorsum of the hand, or the antecubital fossa. The dorsum of 
the hand is predominantly selected as the first choice, as the veins are superficial and 
clearly visible. Although the veins might move around if the skin is not taught, the 
underlying bones of the hand can be used to gain additional support; however the 
dorsum of the hand may be a painful site for venepuncture and topical analgesia is often 
required. The antecubital fossa, although not being the primary choice has large and well 
tethered veins; nevertheless, the veins are in close proximity to other major vessels and 
structures. The selection of the site depends on the experience of the practitioner 
(Malamed, 2010; Girdler et al, 2009). 
Titration is achieved by incrementally administering the sedative agent according to the 
patient’s response. The clinician must continue to communicate with the patient and look 
for signs of adequate sedation level, which are as follows (Malamed, 2010; Girdler et al, 
2009): 
 Slurring and slow speech 
 Calm demeanour 
 Willing to undergo dental treatment 
 Delayed response to verbal commands  
 Positive Eve’s sign (cannot move finger to nose) 
 Verill’s sign (upper eye lid at level of mid pupil) 
The signs may not all occur; it is frequently the case that only 2-3 signs may be present. 
Moreover, the signs may not be dose dependent and may vary from patient to patient 
and visit to visit. Factors that should be considered include the extent of fear, the amount 
of sleep for the previous night, and the level of stress that patient has. 
Monitoring of the patient is critical and should involve both clinician and electrical 
monitoring as described in the Table 1.9: 
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Table 1.9: Methods of Monitoring Conscious Sedation 
Clinician Monitoring  Electrical Monitoring 
Patency of airway Blood pressure 
Respiratory pattern Pulse oximetry  
Pulse Heart rate 
Skin colour End tidal CO2 
Level of consciousness  
 
Induction and Recovery  
The induction process depends on the plasma concentration of the sedative drug; it is 
affected by the rate of injection, cardiac output and circulatory blood volume. The 
sedative agent then travels to the central nervous system through the arterial circulations 
and passing the blood brain membrane. Since the brain is highly perfused, a higher 
concentration of the sedative drug will be reached. With time, the sedative agent will be 
redistributed to the adipose tissue, leading to a decrease in plasma concentrations and 
reversing the blood-brain gradient. The sedative agent will then travel from the brain into 
the blood stream for elimination by ways of the kidney and/or liver (Girdler et al 2009).   
Agents for IV Sedation 
According to the intercollegiate advisory committee for sedation in dentistry (IACSD), IV 
midazolam in a titrated dose is commonly the agent of choice (IACSD, 2015). However, 
IV midazolam is not routinely recommended for conscious sedation in paediatric dental 
procedures in the UK; deeper levels of sedation than intended may be produced and the 
reaction and acceptance of children to intravenous sedation may be unpredictable. 
Furthermore, training of all staff involved is required (Mcintosh et al., 2014: Averley et 
al., 2004; Wilson et al., 2003).  
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Intravenous midazolam is usually administered in a concentration of 1 mg/ml, with a 
maximum single dose of 6-8mg; the maximum dose is 10mg. It is titrated at a rate of 1 
mg (1 ml) per minute until signs of adequate sedation level are visible. Once this effect 
is achieved, titration ceases (Malamed, 2010). Onset of sedation takes 2-3 minutes, with 
a duration of 45-60minutes (Kraus and Green, 2006). 
As with oral midazolam, monitoring for signs of respiratory depression is crucial in IV 
administration of midazolam; respiratory depression is dose dependent and increases 
with midazolam when combined with opioids or alcohol (Kraus and Green, 2006). 
However, the IACSD has stated that multiple anaesthetic drug techniques for use in 
conscious sedation should only be considered by skilled professionals who are trained 
in their use. Furthermore, these methods of conscious sedation should only be used 
when there is a clear clinical justification to do so (IACSD, 2015). 
In cases where midazolam alone does not provide satisfactory anxiolysis, a single dose 
of fentanyl may be given prior to IV midazolam. This drug regimen should only be used 
in patients who are classified as ASA Class I or II and on patients older than 16 years of 
age (IACSD, 2015). fentanyl is an opioid which, as a single dose can produce sedative 
effects. It can be titrated every 3 minutes to a maximum of 50 µg/dose. Onset of sedation 
can be seen in 3-5minutes with sedation lasting up to 60minutes. However, at lower 
doses of 1-2 µg/kg, it can be combined with midazolam for painful procedures (IACSD, 
2015; Kraus and Green 2006).   
For longer procedures, IV midazolam can be combined with propofol. This form of 
conscious sedation involves initially inducing sedation with titrated IV midazolam, and 
maintaining the sedative state with a continued infusion of IV propofol. A dedicated 
sedationist is needed when using propofol. Propofol has no analgesic properties; 
however, it has minimal post-operative confusion and is anti-emetic (IACSD, 2015; 
Melamed, 2010). Propofol given at a titrated dose of 0.5-1mg/kg will result in a sub-
hypnotic state within 3-5minutes. The dose should then be maintained at 3-4.5mg/kg/hr. 
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Due to the narrow safety margin of propofol, its use as a sedative agent is not 
recommended in children (Melamed, 2010; Hosey, 2002). 
The IACSD (2015) did discuss various patient controlled sedative (PCS) techniques; they 
stated that although PCS using Propofol has been studied, the reliability, safety, and 
availability need further investigation. Moreover, with regard to PCS, using midazolam, 
itis not currently being used as a form of conscious sedation within the UK (IACSD, 
2015). 
Indications and Contraindications  
IV sedation is more suitable for adults; in the UK, the age at which IV sedation can be 
done is 16 years and older. It is indicated for patients suffering from severe dental 
anxiety, and those undergoing traumatic surgeries. Both gagging and swallowing 
reflexes must be maintained. Patients with mild medical conditions such as mild asthma 
or mild learning disabilities may similarly benefit from intravenous sedation. 
Patients who have a reported history of allergy to the sedative agent to be used or have 
drug dependency issues are not candidates for IV sedation. Moreover, if they have renal 
or hepatic impairments or have severe psychiatric disorders, IV sedation is 
contraindicated. Pregnant mothers or mothers who are breast feeding should not receive 
IV sedation as well (Melamed, 2010; Girdler et al, 2009). 
Advantages and Disadvantages (Melamed, 2010; Girdler et al, 2009, Meechan et al, 
1998): 
With certain agents, such as midazolam, there is a wide margin of safety with its use. 
Onset is rapid with recovery often occurring within a reasonable period of time, and the 
patient can be sent home on the same day. With IV sedation, titration of the sedative 
agent to the patient’s need is possible. Additionally, IV access is preserved throughout 
treatment; however, cooperation is needed to gain venous access at the start of the 
treatment. Moreover, the patient’s perception and response to pain may be altered, with 
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some agents not producing significant analgesia. Adverse reactions are also more 
pronounced, with the risk of respiratory depression increased when carrying out IV 
sedation. The operator should be aware that once the agent is administered, they must 
wait for the patient to metabolise and eliminate the drug naturally. If an overdose occurs, 
the management involves basic life support and also the administration of an antagonist. 
The antagonist only blocks the effect of the drug and does not increase the rate of 
metabolism. 
1.3 Quality Of Life 
Oral health related quality of life (OHRQoL) is a fundamental component of general 
health and well-being. It is the subjective assessment of the impact of diseases in the 
oral environment on everyday life. The magnitude of factors such as, frequency, severity 
and duration may affect the patients experience and perception of their life overall 
(Gilchrist et al., 2014; Sischo and Broder 2011; Petersen, 2003).  
1.3.1 Quality of Life Measures 
An appropriate measure must be reliable and valid. Furthermore, patient involvement is 
needed in order to evaluate interpretability of the measure and whether the items reflect 
what is important to the patients and assessors. The measures should consider cultural 
or language barriers and be adapted accordingly (Gilchrist et al., 2014). 
When measuring OHRQoL, both negative and positive perceptions of oral health 
outcomes should be investigated, as elements like optimism and resilience can affect 
one’s quality of life (i.e. how well patients can cope with a certain illness) (Sischo and 
Broder, 2011). Various fields have been explored, and are summed up in Figure 1.1: 
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Figure 1.0-1: List of possible domains and factors in OHRQoL (adapted from Sischo and 
Broder, 2011) 
 
The use of OHRQoL measures can be applied in 3 general domains: theoretical, political, 
and practical. It can be used to explore and evaluate various models of oral health or 
ascertain which factors are influential to patient’s health. Furthermore, with a validated 
tool, it can aid in identifying priorities of the public and allocate health funds appropriately. 
Additionally, OHRQoL measures can be used as a clinical governance tool (clinical audit, 
service evaluation, and evaluation of healthcare interventions) (Gilchrist et al., 2014; 
Sischo and Broder, 2011). 
Many measures are available for adults which look at various functional, psychological 
and social domains covering a variety of oral diseases and conditions. Regarding 
measures for children, they can be either answers by the parents as a proxy for the child, 
or by the child themselves, depending on the tool. It should be noted that there are 
differences in cognitive development between adults and children (Glichrist et al., 2014; 
Barbosa and Gaviao, 2008).  
•Disease (gingivitis, caries)
•Symptoms (pain)
•Aesthetics (spacing , crowding)
Oral health
•Chewing 
•Talking 
•Brushing
Functions
•Anxiety
•Happiness 
Social and 
emotional 
•School
•JobEnvironment
•Satisfaction/Dissatisfaction with 
treatment
Treatment 
expectations
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Children’s understanding of self and health is dependent on their age. This process 
begins at the age of 6 years where children show signs of abstract thinking. Moreover, 
children begin comparing themselves with their peers and against norms in terms of 
appearance and personality. By 11 years of age, children have a multidimensional 
understanding of health and use a wide range of indicators to identify illness (Barbosa 
and Gaviao, 2008). 
The available tools to assess children’s OHRQoL are shown in Table 1.10: 
Table 1.10: OHRQoL measures 
Name Authors 
(Year) 
Validity/Reliability Questionnaire 
design 
Other 
Information 
Child 
Perception 
Questionnaire 
(CPQ) 
CPQ 8-10: 
Jokovic et al. 
(2004) 
 
CPQ 11-14: 
Jokovic  et al. 
(2002) 
 Variable scores in 
validity and 
reliability. 
 8-10 year old; 
has 25 items in 4 
domains 
 11-14 year old; 
has 37 items in 4 
domains 
 4 short versions 
based on the  11-
14 year old 
questionnaire; 8 
to 16 items in 4 
domains 
 Multiple 
translations 
available 
Child Oral 
Impact on 
Daily 
Performance 
(C-OIDP) 
index 
Gherunpong 
et al. (2004) 
 Limited evidence 
regarding validity 
and reliability 
 8 items in 1 
domain 
 Developed 
from the adult 
version 
(OIPD) 
 Multiple 
translations 
available 
Child Oral 
Health Impact 
Profile 
(COHIP) 
COHIP: 
Broder et al. 
(2007) 
COHIP-
SF19: 
 Valid for age 8-15 
 Used for caries, 
malocclusion and 
craniofacial 
abnormalities 
 Strong content and 
conduct validity 
with limited 
evidence of 
reliability  
 Original has 34 
items in 5 
domains 
 Short form 
available. Used 
for children as 
young as 7 
years; 19 items 
in 3 d9omains 
 Designed for 
clinical 
situations 
 Multiple 
translations 
available 
  
  
42 
Broder et al. 
(2012) 
Early 
Childhood 
Oral Health 
Impact Scale 
(ECOHIS) 
Pahel et al. 
(2007) 
 Validity of child 
section compared 
to family section 
and global health 
rating (general and 
dental) 
 13 items (9 child 
items and 4 
family items) 
 Answered by 
parents for 
children age 
3-5 
Scale of Oral 
Health 
Outcomes for 
5 yrs (SOHO-
5) 
Tsakos et al. 
(2012) 
 Qualitative phase to 
assess content 
 Further research 
needed 
 7 item 
questionnaire 
 Interview 
based 
questionnaire 
Michigan Oral 
health Related 
Quality of Life 
(MOHRQoL) 
Filstrup et al. 
(2003) 
 Information lacking 
 10 item 
questionnaire for 
child version 
 Answered by 
parents 
Paediatric 
Oral Health 
Related 
Quality of Life 
(POQL) 
Huntington et 
al. (2011) 
 Content checked 
through piloting and 
focus groups 
 Validity checked 
with global oral 
health rating 
 Test-retest done to 
assess reliability 
 10 item with 4 
domains 
 Age range 2- 
16 during 
development.  
Parents 
completed 
questionnaire 
for pre-
school 
children. 
Children 
aged 8 years 
and above 
completed 
their own 
questionnaire 
 
1.3.2 COHIP and COHIP-SF19: 
Child oral health impact profile (COHIP) was developed through a multi-stage process 
for research and clinical practice.  It includes both positive and negative items and was 
initially used on paediatric and orthodontic patients, in 3 languages (English, French, and 
Spanish). The 34 items covered oral health, functional well-being, social/emotional well-
being, school environment and self-image (Gilchrist et al., 2014; Broder et al., 2012). 
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The questionnaire was validated to the “Multidimensional Self Concept Scale” and 
“Global self-concept rating”, which looked at emotional and social aspects of the 
participant. Furthermore, the “Dentofacial image” scale was used to examine the 
participants feeling towards their facial features, and “Social Anxiety Scale” was used to 
evaluate the participant’s feelings of social anxiety in relation to their peer relations and 
interactions (Dunlow et al., 2007). 
The COHIP-SF19 was developed by Broder et al., (2012). Three different populations 
were selected; paediatric dental patients (age 7-17 years), orthodontic patients (age 9-
17 years), and patients with craniofacial anomalies (age 7-18 years). After eliminating 
any content overlap, COHIP-SF19 was compared to the original COHIP measure was 
found consistent validity and reliability. Moreover, the psychometric properties of the 
short version were retained (Broder et al, 2012). 
1.4 Indication of Sedation Need (IOSN): 
The IOSN was developed by Coulthard et al. in 2011 to be used as an indicator of the 
sedation need in adult patients. The purpose of the tool was to aid in clinical judgement. 
Coulthard et al. (2011) suggested it should be used in two settings: 
1. A referral tool used within a commissioned dental service 
2. A health need assessment tool 
The tool assesses 3 domains; anxiety, treatment complexity and health status. 
Treatment complexity and health status are completed by the clinician with the anxiety 
evaluated using the MDAS. A total score from 3-11 is given and patients are ranked as 
minimal, moderate, high or very high sedation need. The authors of the tool advocate 
that those ranked as minimal or moderate may not need sedation, and those ranked as 
high or very high requiring treatment under sedation; furthermore, those scoring 9 and 
above may benefit from general anaesthesia. Table 1.11 was taken from Coulthard et 
al., (2011) and summarises the scoring of the IOSN: 
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Table 1.11. Summary of IOSN (Coulthard et al., 2011) 
IOSN Domain Score Source 
Anxiety 1-3 Based on  MDAS score: 
MDAS between 5-11 is minimal anxiety, scores 1 
MDAS between 12-18 is moderate anxiety, scores 2 
MDAS between 19-25 is high anxiety, scores 3 
Medical history 1-4 A range of medical and behavioural indicators is 
provided; as a general rule, ASA class is utilised: 
ASA I, scores 1 
ASA II and/or strong gag reflex, scores 2 or 3 (depends 
on clinical judgment) 
ASA III, scores 4 
Treatment 
Complexity 
1-4 An indicative list of treatments is provided. If the user 
of this tool is in doubt about the complexity of any given 
treatment, they are asked to score high 
3-4 Minimal need for sedation  No 
5-6 Moderate need for sedation  No  
7-9 High need for sedation Yes  
10-11 Very high need for sedation Yes  
  
1.4.1 Paediatric Indicator of Sedation Need (p-IOSN) 
The IOSN is only used in adults as the anxiety survey used is valid only for adults; 
furthermore, the treatment complexity scoring was based on the treatment needs of adult 
patients. 
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Madouh and Tahmassebi (2016) developed a paediatric version of the IOSN, using a 
similar scoring method. However, treatment complexity was adjusted to better suit 
treatment need of the paediatric patient. Moreover, the anxiety surveys were divided into 
2 age groups (6 to 9 years of age, and 10-16 years of age) with the use of FIS and 
MCDAS-f. The summary of the p-IOSN is shown in the methodology section (section 
2.2, Table 2.2). 
The authors also found that no significant association was noted between the treatment 
outcomes and p-IOSN scoring. Additionally, they suggested that although the tool may 
be helpful in predicting those patients who may benefit from treatment under sedation, 
further research was required to validate the p-IOSN scoring (Madouh and Tahmassebi 
2016). 
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1.5 Aims: 
 To assess the predictability outcomes of treatment under nitrous oxide/oxygen 
inhalation sedation of child patients referred to the sedation unit at Leeds Dental 
Institute (LDI) utilising the Paediatric Indicator of Sedation Need (p-IOSN) as a health 
needs assessment tool. 
 To assess quality of life before and after sedation using the Children Oral Health 
Impact Profile Short form (COHIP-SF19). 
 
1.6 Null Hypotheses: 
 There is no statistically significant association between p-IOSN score and outcome 
of treatment. 
 There is no statistically significant difference in quality of life before and after 
treatment. 
 There is no statistically significant association between baseline quality of life and  
anxiety, gender, treatment  complexity, sedation need and age.
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2.0 MATERIALS AND METHODS 
The present study was carried out in two phases:  
Phase 1: To assess the predictability of treatment outcomes. Baseline questionnaires 
were given at the assessment appointment to assess anxiety, while the clinician 
assessed treatment needs and medical status. Patients were followed-up and their 
outcomes were recorded. 
Phase 2: Quality of Life assessment. Baseline quality of life assessment was carried out 
and for those who completed treatment as planned, 2 weeks following the last 
appointment, a second quality of life assessment was completed, either during a 
prevention appointment or by phone call.  
This chapter discusses the process of ethical approval, data acquisition and statistical 
analyses for both phases. 
2.1 Ethical Approval 
Ethical approval was first sought from the Dental Research Ethics Committee (DREC) 
at the Leeds Dental Institute (LDI) (Appendix 1). Subsequent to the approval by DREC, 
ethical approval and amendments were obtained from the National Research Ethics 
Service (NRES) committee of Solihull in West Midlands (REC reference number: 
14/WM/1019) (Appendix 2a and 2b). Following this the study received approval from the 
Leeds Research and Development Directorate (R&D) in order for it to be performed at 
the Leeds Teaching Hospital Trust (Appendix 3). 
The Chief Investigator (CI: AA) made certain that the present study was carried out in 
full conformance with the laws and regulations of the country in which the research was 
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conducted and the World Medical Association Declaration of Helsinki (World Medical 
Association, 2008). 
2.2 Phase I: Prospective Phase  
This phase utilised the p-IOSN developed by Madouh and Tahmassebi (2016). The 
treatment outcome was obtained prospectively, and the sedation need score was 
calculated. A patient and parent/legal guardian information sheet (Appendices 4 & 5) 
were posted to patients prior to their appointments and were given a copy again at their 
assessment appointments. On the day of their assessment appointment, patients and 
their parents/legal guardians were introduced to the study by AA in the sedation clinic 
pictured below (Fig 2.1).  
 
Upon their willingness to participate, the parent or legal guardian was asked to sign a 
consent form (Appendix 6). Similarly, the child patient was assented to participate using 
age appropriate forms (Appendice 7 & 8). After that, each child participant was asked to 
complete an anxiety questionnaire. There were two anxiety questionnaires; the FIS 
Figure 2-1 Sedation Unit at the Leeds Dental Institute 
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(Appendix 9) was used for children under 10 years of age and the MCDASf (Appendix 
10) for children 10 years of age or older. According to the score the patients achieved 
on the anxiety scale, the CI calculated an “anxiety score” for each child and transferred 
this to the data collection sheet (Appendix 11). The following data were also transferred 
to the data collection sheet:  
a. Age 
b. Gender 
c. p-IOSN : which is the sum of:  
• Anxiety score  
• Treatment complexity score 
• Medical status score 
The means by which p-IOSN was calculated will be discussed below.  
Inclusion criteria: 
- All patients attending the sedation unit for under inhalation sedation at LDI for 
comprehensive dental care 
- ASA class I or II patients 
- Ages 7-16 years 
Exclusion criteria: 
- Patients referred to the sedation unit just for a single procedure (e.g. orthodontic 
extraction) 
- Patients who are unable to communicate directly with the health care personnel 
who is carrying out the treatment 
Calculation of p-IOSN Score 
The IOSN was recently introduced by Coulthard and co-workers in 2011 (Coulthard et 
al., 2011). The IOSN was originally designed to be used by adult patients, however, it 
  
50 
was modified by Madouh and Tahmassebi (2016) in a previous study, using child 
appropriate anxiety measures and treatment complexity rankings (Tables 2.1 and 2.2).  
Anxiety 
Two anxiety scales were used as there was a wide age range of participants; the FIS 
was used for children aged 7- 9 years due to its ease of completion and brevity (FIS 
score ranged 1- 5); the scoring was ranked as following: 
 FIS 1 was scored as minimal anxiety 
 FIS 2-3 were scored as moderate anxiety 
 FIS 4-5 were scored as high anxiety.  
For participants aged 10-16years , the MCDASf was used to evaluate their anxiety 
levels, with a score ranging from 8-40; the scoring was ranked as follows: 
 8-17 as minimal anxiety 
 18-28 as moderate anxiety 
 29- 40 as high anxiety.  
These cut-off points used are identical to those used by Madouh & Tahmassebi (2016) 
in the previous study. 
Treatment Complexity 
The treatment complexity ranking used by Coulthard et al. (2011) was modified by 
Madouh & Tahmassebi (2016) to be more suitable for the child patient, and is explained 
in Table 2.1 below. 
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Table 2.1 Treatment Complexity Rank Score for the Paediatric Version of the 
Indicator of Sedation Need (p-IOSN) 
Rank  Description Score 
Routine Polishing, fluoride application, fissure sealants,  one-
surface restorations 
1 
Intermediate 2-surface restorations, extraction of 1 primary tooth, 
one-quadrant restorative dentistry  
2 
Complex Crown preparation, pulp treatment, extraction of 
multiple primary teeth, multiple-quadrant restorative 
dentistry, extraction of 1 permanent tooth 
3 
High complexity Multiple extractions of permanent teeth, surgical 
extractions, biopsy 
Any treatment considered more complex than above or 
are  
multiples of the above 
4 
 
Medical Status 
The medical status scoring was taken from the IOSN and ranged from 1-4 depending 
on the ASA class:  
 ASA I score of 1 on p-IOSN.  
 ASA II and/or have a strong gag reflex score of 2 or 3 depending on the severity 
of the case.  
 ASA III had a score of 4. 
Table 2.2 shows a summary of the p-IOSN used. 
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Table 2.2 Summary of p-IOSN Scoring System 
p-IOSN 
domain Source Score 
Anxiety  For 7 to 9 years old patients [Facial Image Scale (FIS)]: 
 1 is minimal anxiety 1 
2 or 3 is moderate anxiety 2 
4 or 5 is high anxiety 3 
For 10 to 16 years old patients [Faces version of the Modified 
Child Dental Anxiety Scale (MCDASf)]: 
8-17 is minimal anxiety 1 
18-28 is moderate anxiety 2 
 29-40 is high anxiety 3 
  
Treatment 
complexity 
Routine 1 
Intermediate 2 
Complex 3 
High Complexity 4 
  
Medical status ASA I 1 
ASA II and/or strong gag reflex (depends on clinical 
judgment) 
2-3 
ASA III 4 
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Total p-IOSN 
score 
Anxiety score + treatment complexity score + Medical 
status score 
3-11 
Key: 
p-IOSN: Paediatric Version of the Indicator of Sedation Need 
ASA classification: American Society of Anesthesiologists classification of physical 
health 
ASA I: Healthy  
ASA II: Mild Systemic Disease 
ASA III: Severe Systemic Disease (that does not pose a constant threat to life) 
 
Sample Size Determination 
Statistical advice was sought for the prospective phase of the study. Due to the lack of 
available literature, it was decided to recruit at least 40 (sample used in Madouh and 
Tahmassebi, 2014), with the aim of recruiting at least double (80 or more) (Appendix 
12). 
2.3 Phase II- Quality of Life Assessment 
The COHIP-SF19 was used to assess quality of life of school-aged children. This short 
form of the COHIP was found to be a reliable and valid method to assess oral health-
related quality of life for all school-aged children by Broder and co-authors (2012).   
Calculation of Quality of Life 
A 19-item questionnaire constructed by Broder and co-authors (2012) was used. The 
child was interviewed in the presence of their legal guardian. The questionnaire was 
completed initially during the assessment appointment, then 2 weeks following the final 
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appointment; this was carried out either in the prevention appointment, or by phone call 
following a verbal consent of the legal guardian. 
Sample Size Determination 
Statistical advice was sought and it was advised to recruit 30 participants for this part of 
the study. However, it was decided to assess the quality of life of all of the participants 
in the study.  
Statistical analysis used: 
 Descriptive statistics to display demographic data and frequencies 
 Wilcoxon signed rank test and effect size to assess difference in baseline QoL scores 
and post-treatment scores 
 Single and multiple linear regressions to assess predictability of baseline QoL scores 
against multiple variables 
 Binary logistic regression to assess predictability of treatment outcomes against multiple 
variables 
 Effect size calculated by dividing mean change in scores by the standard deviation of 
the pre-treatment scores, 
o Less than 0.2 indicate a small effect size 
o 0.2–0.7 a moderate effect size 
o  >0.7 a large effect size 
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3.0 RESULTS 
This chapter contains the results of the two phases: 
 Phase I: Prospective phase where the predictability of the treatment outcome 
was compared to the p-IOSN and other related factors. 
 Phase II: Quality of Life assessment. Comparing scores before and after 
treatment and assessing predictability of baseline quality of life scores. 
3.1 Phase I: Prospective Phase  
Figure 3.1 summarises the recruitment of patients. The subjective assessment of 
patients suitability showed to have high sensitivity (48/51 = 94%), with only 3 children 
being referred back for treatment under local anaesthetic. Only 26 participants were 
rated as high sedation need. Three participants were given an outcome of “Others” as 
they were unable to give informed consent for treatment at the time of the assessment; 
requesting more time to decide on the different options that were discussed. 
 
 
 
 
 
 
 
 Completed baseline COHIP-SF19 
and anxiety questionnaire. 
 IOSN score calculated 
Total patients 
recruited = 97 
Treatment completed 
as planned = 47 
Attended review 
appointment = 31 
 Answered follow-up COHIP-
SF19 questionnaire 
16 failed to attend review 
appointment and could not be 
contacted 
Figure 3.1: Flow diagram of patient recruitment 
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Table 3.1 Descriptive information of participants recruited in the study 
 
Age 7-9yrs = 
49 
10-16yrs = 
48 
 
Range = 7-
15 
Mean (SD) 
= 10.06 
(2.593) 
   
Anxiety Low = 20 
 
Moderate = 
55 
 
High = 22 
 
    
Treatment 
Complexity 
Routine = 
3 
 
Intermediate 
= 9 
 
Complex = 
74 
 
Highly 
complex = 
11 
 
   
Medical 
Complexity 
ASA 1= 89 ASA 
2/strong gag 
reflex = 8 
     
Sedation 
Need 
Minimal = 
5 
 
Moderate = 
66 
 
High = 26 
 
    
Outcome 
of 
treatment 
Completed 
as 
planned = 
47 
 
Modified 
plan 
completed = 
1 
 
Abandoned 
and went 
to GA = 20 
 
Abandoned 
and went 
to LA = 3 
 
Failed 
to 
attend 
= 5 
 
Others 
= 3 
 
Treatment 
ongoing = 
18 
 
Male, 44, 45%
Female, 53, 55%
Male Female
Figure 3.2: Gender distribution 
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A total of 97 participants were recruited by the chief investigator. There were slightly 
more female patients (n=53) than male patients (n=44), with a mean age of 10.06 years 
(SD 2.593). The majority of the patients were of moderate anxiety (n=55/97) and 
needing mainly complex dental treatment (n=74/97). A large proportion of the children 
were ASA class I (n=89/97), and had moderate sedation needs (66/97). 
Regarding the outcome of treatment, 47/97 completed treatment as planned, with 20 
patients referred to treatment under general anaesthesia and a further 18 patients still 
undergoing care (Table 3.1).
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Table 3.2 Cross tabulation of Outcome of treatment vs Various Factors 
Outcome Gende
r 
Age Treatment complexity Anxiety Sedation need 
M F 7-
9yr
s 
10-
11yr
s 
Routin
e 
Intermediat
e 
Comple
x 
Highly 
comple
x 
Lo
w 
Moderat
e 
Hig
h 
Minima
l 
Moderat
e 
Hig
h 
Completed 
as planned 
21 26 21 26 2 8 34 3 7 31 9 3 34 10 
Modified 
treatment 
completed 
0 1 1 0 0 0 1 0 0 1 0 0 1 0 
Treatment 
abandone
d – 
referred to 
GA 
8 12 8 12 1 1 16 2 5 7 8 1 11 8 
Treatment 
abandone
d – 
referred to 
LA 
3 0 3 0 0 0 3 0 3 0 0 1 2 0 
Failed to 
attend 
4 1 3 2 0 0 4 1 0 5 0 0 3 2 
Others 2 1 3 0 0 0 3 0 0 3 0 0 3 0 
18 participants still undergoing treatment (n=79)
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Table 3.3 Binomial Logistic Regression between "Treatment Completed" and "Treatment Abandoned- patient referred to GA" 
Variable OR Significance 95% CI for OR 
Lower Upper 
Low Anxiety  0.290   
Moderate Anxiety 0.280 0.116 .057 1.367 
High Anxiety 436228284.128 0.999 .000 . 
Routine Treatment  0.931   
Moderate Treatment 0.000 1.000 .000 . 
Complex Treatment 1.902 1.000 .000 . 
Highly Complex Treatment 726503931.611 1.000 .000 . 
Minimal Sedation Need  1.000   
Moderate Sedation Need 0.278 1.000 .000 . 
High Sedation need 0.000 1.000 .000 . 
Younger age group 1.614 0.452 .463 5.624 
Male 1.493 0.523 .436 5.110 
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3.1.1 Completed as Planned vs Referred to GA 
When comparing those that completed treatment as planned against those that were 
referred for treatment under GA (Table 3.2) in terms of anxiety, the majority were 
classified as having “moderate anxiety” (34/47 vs 11/20); however, a further 8/20 
participants that were referred to having treatment under GA were classified as having 
“high anxiety”. With regards to sedation need, 31/47 were classified as having “moderate 
sedation need” in the “completed as planned” group; for those participants that were 
referred to GA, the sedation need was variable with 8 being “high sedation need”, 7 
being “moderate sedation need” and 5 being “low sedation need”. 
3.1.2 Binomial Regression to Assess Predictability of Treatment Outcome 
Table 3.2 above shows that for some of the variables, the sample of participants in 
certain outcomes are low. The majority of participants had completed the treatment as 
planned (47/97), followed by treatment abandoned and being referred to GA (20/97) 
(Table 3.1). For this reason, we have compared those two outcomes in terms of their 
predictability and the variables measured. A binomial logistic regression was preformed 
to ascertain the effects of anxiety, treatment complexity, sedation need, age group and 
gender on the predictability of the outcomes. There were no statistically significant 
associations between the treatment outcomes and the variables tested (Table 3.3). 
3.1.3 Referral to General anaesthesia 
As seen in Table 3.4, there were slightly more females and 11-16 year old participants 
referred to have treatment under general anaesthesia, with only one participant 
classified as “minimal sedation need”. 
The most common reason for referral was anxiety (15/20). Other reasons included 
severe gag reflex (2/20), poor cooperation (1/20), feeling unwell after sedation (1/20), 
and parents feeling child would not cope with sedation (1/20).  Only 4/20 of those 
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referred to GA were symptomatic, two of them refusing any treatment under sedation. 
Out of those who were referred for treatment under GA, 5/20 managed some treatment 
under sedation. 
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Table 3.4: Reasons for referral to GA and treatment needed 
Age of patient 
(Gender) 
Reason for failed Sedation Treatment completed under Sedation Treatment left to be completed Symptoms 
present 
8 yrs. (F) Anxious about extraction, 
refused to accept LA 
None Restoration of 4 permanent teeth and 3 primary teeth No 
15 yrs. (M) Complex extraction of 
crowned tooth 
None Extraction of 3 permanent teeth No 
12 yrs.(F) Anxious about extractions Restoration of 1 adult tooth Extraction of one adult tooth No 
15 yrs. (F) Needle phobic, not 
accepting Local 
anaesthetics 
None Extraction of 3 permanent teeth and 2 primary teeth 
Restoration of 1 permanent tooth 
Yes  
9 yrs. (M) Very anxious patient None Extraction of 4 primary teeth 
Restoration of 4 permanent teeth and 2 primary teeth 
No 
8 yrs. (F) Uncooperative patient, 
managed LA but cannot 
manage treatment 
None Extraction of 1 primary tooth 
Restoration of 4 primary teeth 
No 
9yrs (F) Very anxious patient None Restorations of 4 permanent teeth and 2 primary teeth No 
11yrs (F) Anxious about multiple 
extractions 
None Extractions of 4 Permanent teeth Yes 
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14 yrs. (F) Anxious about treatment, Ok 
with LA 
Restoration of 1 adult tooth Restoration of 1 adult tooth Yes, on 
eating 
11 yrs. (M) Very anxious None Extraction of 6 primary teeth 
Restoration of 4 permanent teeth and 1 primary tooth 
No 
7yr (F) Anxious and developed 
infection 
None Extraction of 5 primary teeth Restoration of 2 primary teeth Yes 
13 yrs. (M) Severe Gag Reflex Restoration of 1 permanent tooth Restoration of 3 permanent teeth No 
13 yrs. (F) Anxious with LA None Restoration of 4 permanent teeth No 
13 yrs. (F) Very Anxious None Extraction of 1 permanent tooth and 2 primary teeth 
Restoration of 1 permanent tooth 
No 
7 yrs. (M) Anxious about trying nasal 
hood 
None Extraction of 4 primary teeth 
Restoration of 2 permanent teeth and 1 primary tooth 
No 
11 yrs. (M) Anxious about treatment None Extraction of 2 permanent teeth 
Restoration of 4 permanent teeth  
No 
7 yrs.(M) Tried sedation, became 
anxious 
Fissure sealing 4 teeth Extraction of 2 primary teeth No 
14 yrs.(F) Severe gag reflex, felt unwell 
with sedation 
None Restoration of 5 permanent teeth No 
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8 yrs. (M ) Father feels son wont cope 
with sedation 
None Extraction of 4 primary teeth 
Restoration of 2 permanent teeth and 2 primary teeth 
No 
13 yrs.(F) Very anxious regarding 
extraction 
Extraction of 1 permanent tooth Extraction of 1 permanent tooth No 
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3.2 Phase II - Quality of Life Assessment 
All of the 97 participants who were recruited in this study completed the COHIP-SF19 
questionnaire. Out of those who completed the treatment under IHS as planned, a total 
of 31/47 (66%) completed both initial and final QoL assessment. Out of those that did 
not complete the questionnaire, 4 were discharged back to their GDP and chose not to 
attend the review appointments and another 12 participants did not attend the review 
appointment and none could be contacted by telephone. 
Table 3.5A displays the frequency of answers for the baseline QoL assessment. It is 
interesting to note that In the oral health wellbeing domain, a large proportion of the 
participants reported to have pain in their teeth almost all the time or fairly often (73/97) 
prior to any dental treatment in the sedation clinic. Regarding bleeding gums and bad 
breath, the answers were more varied with the majority being “sometimes” for bad breath 
(36/97) and “almost never” (48/97) for bleeding gums. 
The baseline scores in the functional wellbeing domain were largely positive, with the 
exception of the question  “had difficulty keeping your teeth clean?” 44 out of97 
participants selected “sometimes” and 31/97 participants selected “fairly often”. 
Regarding the social/emotional wellbeing domain, there were variable responses to 
“being unhappy or sad” and “felt worried or anxious”; though the majority answered 
“almost never” for “being unhappy or sad” (42/97), “sometimes” and “fairly often” were 
selected in 78/97 of respondents. “Avoiding smiling was noted to be answered positively 
with more than half of the participants answering as “never” or “almost never” (55/97); 
however, 33 responded as “sometimes” avoiding smiling, with 1 participant responding 
as “almost all the time”.  
A similar trend of responses was seen between “felt that you looked different” and “been 
worried about what people think about your teeth, mouth or face”, with the majority 
answering “never” (62/97 and 74/97) respectively. Though most participants answered 
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“never” or “almost never” with regards to bullying, 23 out of 97 did respond to this 
question with “fairly often” and “sometimes”. More than half of the children responded    
as “sometimes” missing school for any reason (64/97).  With regards to “not reading and 
speaking out loud”, the answers were varied with 27/97 as “never”, 34/97 responding as 
“almost never” and 29/97 as “sometimes”. More than half of the participants responded 
as “almost all the time” or “fairly often” with regards to confidence and attractiveness 
(62/97 and 76/97 respectively). 
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Table 3.5A  Frequency Table for baseline responses of COHIP-SH19 
Domain Scoring 
Oral Health Wellbeing Almost all the time Fairly often Sometimes Almost never Never 
Q1. Had pain in your 
tooth/teeth 
32 41 18  4 2 
Q2. Had discoloured teeth or 
spots on your teeth? 
--- --- 11  37  49  
Q3. Had crooked teeth or 
spaces between your teeth? 
--- 1  7  33  56  
Q4. Had bad breath? --- 2 36  39  20  
Q5. Had bleeding gums? 1  3  31 48  14  
Functional Wellbeing Almost all the time Fairly often Sometimes Almost never Never 
Q6. Had difficulty eating 
food you like to eat? 
--- 2 17  42 36 
Q7. Had trouble sleeping? --- 1  19 38 39 
Q8. Had difficulty saying 
certain words? 
--- --- --- 16 81 
Q9. Had difficulty keeping 
your teeth clean? 
2 31 44 16 4 
Social-Emotional Wellbeing Almost all the time Fairly often Sometimes Almost never Never 
Q10. Been unhappy or sad? --- 11 36  42 8 
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Q11. Felt worried or 
anxious? 
10 39 39 9 --- 
Q12. Avoided smiling or 
laughing? 
1  8 33 44 11 
Q13 Felt that you look 
different? 
--- 3  3  30 62 
Q14. Been worried about 
what people think about 
your teeth, mouth or face? 
--- --- 3  20 74 
Q15. Been teased, bullied, or 
called names by other 
children? 
--- 3  21 42 31 
Q16. Missed school for any 
reason? 
1  16 64 14 2 
Q17. Not wanted to 
speak/read out loud in class 
2 5 29 34 27 
 Never Almost never Sometimes Fairly often Almost all the time 
Q18. Been confident? --- 5 30 45 17 
Q19. Felt that you were 
attractive (good looking) 
--- 4 17 39 37 
  
69 
 
3.2.1 Changes in QoL following dental treatment under inhalation sedation 
It can be seen from Table 3.5B that overall, most participants responded more 
favourably to all three domains of the questions after the completion of treatment under 
IHS.  
It is important to note in particular the responses to the social-emotional wellbeing 
domain, in particular in respect to confidence and attractiveness. There was an increase 
in respondents that answered “fairly often” or “almost all the time” for confidence and 
more participants answered “almost all the time” for attractiveness.
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Table 3.5B Quality of Life scores before and after treatment (n=31) 
Domain Scoring 
Oral Health Wellbeing Almost all the time Fairly often Sometimes Almost never Never 
Q1. Had pain in your tooth/teeth 7 --- 21 --- 2 --- 1 11 --- 20 
Q2. Had discoloured teeth or spots 
on your teeth? 
--- ---  --- 4 --- 12 4 7 27 
Q3. Had crooked teeth or spaces 
between your teeth? 
--- ---  --- 1 4 11 18 19 9 
Q4. Had bad breath? --- ---  --- 11 4 13 17 7 10 
Q5. Had bleeding gums? --- ---  --- 18 2 7 14 6 15 
Functional Wellbeing Almost all the time Fairly often Sometimes Almost never Never 
Q6. Had difficulty eating food you 
like to eat? 
--- --- 1 --- 8 4 18 22 4 5 
Q7. Had trouble sleeping? --- ---  1 7 4 19 21 5 5 
Q8. Had difficulty saying certain 
words? 
--- ---  ---  1 9 11 22 19 
Q9. Had difficulty keeping your teeth 
clean? 
--- --- 9 1 16 13 5 14 1 3 
Social-Emotional Wellbeing Almost all the time Fairly often Sometimes Almost never Never 
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Q10. Been Unhappy or sad? --- ---  --- 14 5 14 23 3 3 
Q11. Felt worried or anxious? --- 1 2 2 14 10 12 15 3 3 
Q12. Avoided smiling or laughing? --- --- 2 1 8 8 17 11 4 11 
Q13 Felt that you look different? --- ---  
 
---  1 9 4 22 26 
Q14. Been worried about what 
people think about your teeth, 
mouth or face? 
--- ---  --- 1 1 5 4 23 26 
Q15. Been teased, bullied, or called 
names by other children? 
--- ---  --- 6 1 12 11 13 19 
Q16. Missed school for any reason? --- --- 3 1 21 16 6 11 1 8 
Q17. Not wanted to speak/read out 
loud in class 
--- --- 2 1 6 6 12 7 11 17 
 Never Almost never Sometimes Fairly often Almost all the time 
Q18. Been confident? --- --- --- --- 7 4 12 17 7 10 
Q19. Felt that you were attractive 
(good looking) 
--- --- --- --- 4 2 13 12 14 17 
* Grey columns represent baselines scores and white columns are after treatment scores 
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The mean baseline QoL score was found to be 23.14 (9.51), while following dental 
treatment the mean score has changed to 13.97(8.30), indicating that following 
treatment the total scores showed an improvement in QoL. Improvements were also 
seen in all 3 domains (Table 3.6A).  
As the data was found not to be normally distributed, Wilcoxon signed rank test was 
used to calculate the significance.  Though we found there to be a significant difference 
between baseline and post-treatment scores, and between the domains at baseline and 
post treatment, the effect size was large for both the total score (0.964), oral health 
wellbeing (1.541), and social-emotional well-being (0.849) (Table 3.6A). 
Table 3.6A Quality of Life Score 
COHIP-SF19 Number Mean (SD) 
Prior to Treatment 97 23.14(9.51) 
Oral Health Well-
being 
 6.67 (2.57) 
Functional Well-
being 
 3.92 (2.00) 
Social-Emotional 
Well-being 
 12.49 (5.90) 
After Treatment 31 13.97(8.30) 
Oral Health Well-
being 
 2.71 (1.94) 
Functional Well-
being 
 3.74 (1.90) 
Social-Emotional 
Well-being 
 7.48 (5.25) 
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Table 3.6B Changes in Quality of Life 
COHIP-
SF19 
Direction 
of change 
Number Mean 
Rank 
Significance 
(SD) 
Effect 
size 
Total Score Positive 26 18.19 0.000 0.964 
Negative 5 4.60 
Ties 0  
Oral Health 
Well-being 
Positive 29 15.00 .000 1.541 
Negative 0  
Ties 2  
Functional 
Well-being 
Positive 16 12.31 .019 0.09 
Negative 6 9.33 
Ties 9  
Social-
Emotional 
Well-being 
Positive 21 16.57 .001 0.849 
Negative 7 8.29 
Ties 3  
Wilcoxon signed rank test 
 
3.2.2 Linear Regression Assessing Predictability of Baseline QoL 
Single and multiple logistic regression analyses were used to assess the significance 
that various factors may have as a predictor of QoL. The ability of five variables (Table 
3.6B) to predict baseline QoL were examined in a univariate analysis. Only changing 
from high anxiety to low anxiety was found to be a statistically significant predictor for 
QoL, with more than a 6-point improvement in QoL. 
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Table 3.7. Single logistic regression analysis of the predictor variables for 
baseline QoL 
Variable 
Categories n B 95% CI p-Value 
Anxiety 
Low 20    
Moderate 55 1.040 (-3.765)- 5.847 0.668 
High 22 6.632 0.946-12.318 0.023 
Gender 
Male 44    
Female 53 -3.147 (-6.963)-0.670 0.105 
Treatment 
Complexity 
Highly 
complex 
11    
Complex 74 1.514 (-4.415)-7.442 0.613 
Moderate 9 3.875 (-4.821)-
12.571 
0.378 
Routine 2 5.500 (-6.798)-
17.798 
0.377 
Age group 
7-9 years 49    
10-16 years 48 -2.554 (-6.372)-1.264 0.187 
Sedation 
High 26    
Moderate 66 -3.716 (-8.064)-0.663 0.093 
Minimal 5 -1.131 (-10.301)-
8.040 
0.807 
 
When assessing the variables independently, a statistically significant association was 
found between low and high anxiety levels, and a positive effect on QoL. Though the 
other variables were not statistically significant, as anxiety increases, QoL decreases. A 
similar trend was found when evaluating treatment complexity. The reverse is true for 
sedation need. Older age groups and being female also were shown to lead to an 
improved quality of life (Table 3.7). 
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Table 3.6 . Multiple logistic regression analysis of the predictor variables for 
baseline QoL 
Variable β S.E. B 95%CI p-Value 
Moderate Sedation 
Need 
0.021 2.950 0.429 (-5.430) – 
6.287 
0.885 
Minimal Sedation 
Need 
0.077 5.041 3.291 (-6.720)-
13.303 
0.515 
Moderate Anxiety 0.054 2.481 1.038 (-3.889)-5.966 0.677 
High Anxiety 0.315 3.758 7.126 (-0.337)-
14.589 
0.061 
When controlling for sedation need, changing from high to low anxiety was no longer 
found to be statistically significant (p-Value=0.061) (Table 3.8). 
It should be noted that no patients with minimal sedation were classified as having High 
anxiety and no patients with high sedation need were classified as having Low anxiety 
(Table 3.9). The plot below (Figure 3.3) illustrates that as anxiety increases, the QoL 
score increases (i.e. poor QoL) with moderate and high sedation need. 
Table 3.7 Cross-tabulations showing Anxiety vs Sedation need 
  
 Sedation Need 
Minimal 
Sedation Need 
Moderate 
Sedation Need  
High Sedation 
Need 
Anxiety 
Level 
Low Anxiety 1 19 0 
Moderate 
Anxiety 
4 43 8 
High Anxiety 0 4 26 
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Figure 3.3. Plot of Changes in Baseline Qol Score vs Different Levels of Anxiety 
and Sedation Need 
 
 
 
 
 
Estimated Marginal Means of QoL 
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4.0 DISCUSSION 
4.1 Methodology and Study design: 
The IOSN tool was developed by Coulthard et al. (2011) to be used as either a: 
1. Referral tool to aid in identifying suitable patients who may benefit from treatment 
under sedation (Goodwin et al., 2012); tool completed by referring dentist. 
2. Health need assessment tool to assess the needs of the population and 
commission dental services accordingly (Pretty et al., 2011). 
The IOSN is a relatively recent tool that can be used as an adjunct to clinical judgement. 
Though the authors produced further publications of the use of IOSN as described 
above, only one study investigates the use of IOSN in children (Madouh and 
Tahmassebi, 2016), which led to the development of the p-IOSN. With that in mind, the 
investigators of this current study decided to expand on the existing available evidence 
regarding the use of the p-IOSN. 
Although the IOSN was completed by the referring dentist (Goodwin et al., 2012), the p-
IOSN was completed following referral of the patient to the sedation department. The p-
IOSN was used to evaluate suitability as a referral tool, expanding on the recent pilot 
study by Madouh and Tahmassebi (2016).  
Similar methodology was used as for the study by Madouh and Tahmassebi (2016); 
however, the age of inclusion was adjusted to suit the quality of life measures used. The 
patients referred to the sedation clinic were followed-up and the outcomes were 
assessed. The outcome of treatment was compared to various factors incorporated in 
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the p-IOSN to help evaluate whether these factors could assist in predicting treatment 
outcome. 
Though multiple OHRQoL measures are available for use, COHIP was found to have 
very strong positive evidence of content and construct validity (Gilchrist et al., 2014). 
Furthermore, a shorter version was available (COHIP-SF19), which was compared to 
the COHIP and global health self-rating score for validity. Additionally, the COHIP-SF19 
was used for paediatric patients aged 7 years and older. Both COHIP and COHIP-SF19 
have been used worldwide with multiple translations available (Gilchrist et al., 2014; 
Broder et al., 2012). The authors who developed COHIP-SF19 stated the time-frame it 
covers is 3 months (Broder et al., 2012). The investigators therefore agreed to conduct 
the review QoL assessment 2 weeks following their last appointment.  
As COHIP-SF19 covered a large age range and is a concise tool that has been validated 
to previous versions (Broder et al., 2012) the investigators agreed to select this tool to 
assess quality of life before and after treatment.  
4.1.1 Sample Size Calculation 
At the time of study design, there was a lack of published articles conducting a similar 
study. Advice was sought from a qualified statistician at the University of Leeds who 
advised the following:  
1. With regards to the prospective phase of this study a previously conducted study, 
using the p-IOSN, recruited a total of 40 patients. Therefore, it was suggested to 
recruit at least 40; however, the investigators of the study agreed to recruit at 
least double. The recruitment began in February 2015 and ended in March 2016.  
2. Regarding the second phase (QoL Assessment), there was a lack of available 
studies conducting quality of life before and after treatment involving inhalation 
sedation, so it was decided to recruit at least 30 participants. 
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4.1.2 Strengths and limitations of study design:  
The p-IOSN tool was completed at the first appointment on the sedation clinic (i.e. 
assessment appointment). At this stage all patients attending this appointment had been 
subjectively assessed by qualified dentists and consultants. 
The quality of life assessment tools were answered by the children and not by the 
parents as proxy.  Though multiple measures using the parents to evaluate their child’s 
quality of life have been validated, the use of an age appropriate questionnaire 
answered by children can provide reliable and valid results (Barbosa and Gaviao, 2008).  
Furthermore, younger participants completed the COHIP-SF19 with the help of the lead 
investigator to ensure clarity of the questionnaire. Though this may lead to interview 
bias, it ensured that all participants understood the questions asked. 
4.2: Quality of life before and after treatment under inhalation 
sedation 
A total of 47 participants were eligible with 31 completing both before and after 
questionnaires; however, 4 were discharged and decided to be reviewed by their family 
dentist, the remaining failed to attend their appointments and could not be contacted 
through the provided phone numbers. Paediatric patients are dependent on their primary 
caregiver with respects to their oral and general health. Hallberg and co-authors (2008) 
conducted qualitative interviews of 12 parents to examine why they failed to bring their 
children to dental appointments; the overriding theme was being “overloaded in 
everyday life” and giving oral health low priority. Furthermore, the authors go on to 
mention that parents lacked dental care traditions and trust in the dental services, with 
some lacking parental confidence. There are local measures set up by the Leeds 
Teaching Hospital Trust to aid in reducing rates of missed appointments, however, 
clinicians should work with parents to ensure continuity of care. 
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This study showed that quality of life improved following completion of dental treatment 
under inhalation sedation; improvements were seen in total score and in the domain 
scores.  Current published evidence only discusses changes in OHRQoL following 
dental treatment only under general anaesthesia, (Gaynor and Thompson, 2012; 
Jankauskiene and Narbutaite, 2010; Klassen et al., 2009; White et al., 2003), with no 
literature found on OHRQoL following completion of dental treatment under inhalation 
sedation.   
Gaynor and Thompson (2012) used parental- caregiver perception questionnaire (P-
CPQ). A total of 144 children were reviewed 1 month following their general 
anaesthesia. They found a statistically significant difference when comparing the 
change in quality both in the total score and domains (p value < 0.001). Effect size 
calculations showed large effect for the difference in total scores (0.88), and oral 
symptoms (1.22). The P-CPQ divided the emotional and social domains separately with 
large effect size reported for emotional domain (0.71). The authors did discuss such 
weakness, such as mixed method of data collection for post-operative scores, they failed 
to mention concerns regarding the time frame. The P-CPQ questionnaire covers a 3-
months period, where the authors conducted the post-operative review only 1 months 
after the general anaesthesia. Though the current study used a different measure of 
quality of life under inhalation sedation, similar results were found. Furthermore, 
Barbosa and Gaviao (2008) found that parents could provide important information 
regarding their child’s OHRQoL, however, some parents may lack knowledge in terms 
of social and emotional experiences. 
A systematic review prepared by Jankauskiene and Narbutaite (2010) found immediate 
improvement in the child’s quality of life was seen, with a positive impact on families. 
However, long term effects were not investigated. As multiple measures were used 
(Children OHRQOL, Francis Hospital Children OHRQoL, Dental Discomfort 
Questionnaire, P-CPQ, ECOHIS, interviews), they concluded that a more accurate 
comparison may not be possible. There is also no agreement on which measure should 
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be used for analysis of quality of life for children; the authors felt that there was a need 
to standardise the process to analyse children’s OHRQoL. 
Klassen and co-authors (2009) included two control groups in their study investigating 
changes in quality of life following treatment under general anaesthesia using ECOHIS. 
Their results showed that the treatment group had a significant positive change in their 
quality of life score when compared to the control group. Interestingly, dental fear was 
still present after treatment.  However, the study did not compare scores within the 5 
domains of the ECOHIS questionnaire, or discuss the effect size. Nonetheless, their 
study incorporated the use of the control group which was not done in other studies 
including this current study. 
White and co-authors (2003) investigated changes in quality of life through a 10 item 
questionnaire covering 3 aspects; parental satisfaction, parental perception on the 
impact of GA on the child’s OHRQoL in terms of physical health and social well-being. 
Though the paper was not clear on how the satisfaction was assessed, the parental 
perception on the impact of GA were assessed using closed-ended positively term 
statements; descriptive statistics were performed.  The results did show improvement 
2-4 weeks after treatment; however, the long-term effects were not investigated. 
A more recently published systematic review regarding OHRQoL following dental 
treatment under general anaesthesia found similar findings, with the majority of the 
published literature using measures answered by parents as a proxy. Furthermore they 
reported that although overall improvements were noted, this was not always consistent 
in the subscales (Knapp et al., 2016). 
The present study found similar results to the papers discussed above; however, the 
studies mentioned used parents as proxy (Gaynor and Thompson, 2011; Klassen et al., 
2009; White et al., 2002); furthermore, treatment modalities varied to the current study. 
This study is the first of its kind to assess the impact Inhalation Sedation has on the child 
from the child’s perspective.  
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4.3 Predictability of Baseline Quality of Life: 
White and co-authors (2003) assessed predictors of parental perceptions of better oral 
health using multivariate regression. Their analysis showed that being female had a 
statistically significant positive effect on quality of life. Additionally, being “pain free”, 
“looking better”, “smiling more”, and “more social” were seen to have a similar effect. 
Due to the design of the questionnaire, the parents only completed a survey following 
dental treatment on behalf of their child. The effect of gender, though positive in the 
current study was not found to be statistically significant. 
When not controlling for other factors, this current study found that being highly anxious 
had a negative effect on quality of life, this was not seen when comparing between low 
and moderate anxiety.  After analysing the effect sedation need had on baseline quality 
of life, it was not significant, but was included in the multiple logistic regression as the 
investigators felt it was of some clinical significance. The analysis then showed that 
when controlling for sedation need, being highly anxious was not found to be 
significantly related to quality of life.  
4.4 Treatment outcomes under inhalation sedation: 
This study showed 48% completion of treatment (47/97 participants), with 18 
participants still undergoing care; excluding those that did not have a final outcome, the 
percentage increased to 59% (47/79). The proportion was lower than the previously 
conducted pilot study (Madouh and Tahmassebi 2016) and in published literature 
(Elledge et al., 2007; Foley, 2005; Bryan 2002; Crawford 1990) where success of 
sedation was reported to be as high as 93%.  
Though Elledge and authors (2007) reported 27/29 (93%) of patients referred for 
sedation assessment were treated successfully using conscious sedation, 10/29 (34%) 
were under inhalation sedation and 17/29 (59%) were under intravenous sedation. 
Furthermore, a retrospective assessment showed that while 19/46 (41.0%) patients 
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were referred for treatment using inhalation sedation, 12/46 (26%) managed to accept 
treatment under inhalation sedation; no information was provided regarding the success 
of the treatment. The current study only looked at treatment outcomes under inhalation 
sedation, however, the figures for success of treatment under inhalation sedation 
published by Elledge and authors (Elledge et al., 2007) are lower than that of the present 
study. 
A total of 20 participants (21%) failed to complete treatment and were consequently 
referred for treatment under general anaesthesia; the majority failed to complete 
treatment due to anxiety (15/20). Failure rates reported in literature varied from as low 
as 3.3% (Bryan, 2002) to 12.5% (Madouh and Tahmassebi, 2016). It should be noted 
that despite the higher failure rate reported in this study, only 4/20 reported having 
symptoms with three of the participants refusing any treatment. 
The findings of the current studies varied in terms of outcomes when compared to the 
published literature. Bryan (2002) assessed outcome of treatment under inhalation 
sedation, this was based on retrospective data which is prone to bias related to record 
keeping such as insufficient or lost data. The recruitment process in this study was 
prospective where patients were followed-up until an outcome was achieved or the study 
was completed. 
Other published literature had solely focused on the completion of inhalation or referral 
to general anaesthesia as the outcomes; other outcomes such as modified treatment 
completed, referral to local anaesthesia, or failure to attend were not assessed (Shaw 
et al 1996; Crawford 1990). Furthermore, both Shaw et al (1996) and Crawford (1990) 
recruited patients who were treatment planned for minor surgeries or extractions. The 
current study assessed six outcomes with a seventh category for patients who at the 
end of the study were still undergoing treatment. Though the previous pilot study looked 
at five outcomes (Madouh and Tahmassebi, 2016), a sixth was added as three 
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participants completed the initial baseline questionnaires but asked for more time to 
think about other options.  
4.5 Predictability of Treatment Outcomes 
As this study assessed six possible outcomes against five factors, the lead investigator 
found multiple outcomes with low number cases (e.g. a small proportion of patients were 
given the outcome of modified treatment completed, referral for treatment under local 
anaesthesia or failed to attend). This does show that the subjective assessment carried 
out prior to referral to the sedation department is adequate as only 3/97 participants 
decided to opt out of treatment under sedation. 
However, when comparing outcomes of treatment to the five factors, some data sets 
had a total of zero participants or answers (refer to Table 3.8; intermediate and routine 
treatment complexity scores). This would lead to unreliable results following statistical 
analysis, it was therefore decided to only compare “treatment completed as planned” 
with “treatment abandoned and patient referred to GA”.  
The results of the current study showed no statistically significance in terms of treatment 
outcome and gender. Similar findings were reported by Madouh and Tahmassebi 
(2016), where no significant difference was found when comparing treatment outcomes 
against gender and p-IOSN scores. Similarly, Foley (2005) reported that when 
comparing gender to behaviour and outcome scores, little difference was found. Other 
studies failed to mention whether there was any difference when comparing gender to 
treatment outcomes (Hennequin et al., 2012; Soldani et al., 2010; Bryan, 2002).  
With respects to age and treatment outcome, no significant difference was noted 
between younger and older age groups. However, Madouh and Tahmassebi (2016) 
reported that patients younger than 10 years of age were more likely to require GA. This 
was not the case in the current research where 12/20 patients referred to GA were 11 
years and above. Interestingly, Foley (2005) found a statistically significant difference 
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when comparing the age of patients and treatment outcome with more “younger 
patients” unable to complete treatment under sedation. 
The findings of this study showed no statistically significant difference between anxiety 
and treatment outcome. However, those patients that were referred for treatment under 
local anaesthesia (3/97) were all categorised as low anxiety. Furthermore, patients who 
were treated under inhalation sedation had varying levels of anxiety (majority being 
moderate anxiety) with those referred for treatment under general anaesthesia having 
almost an even distribution of anxiety levels. However, Elledge and co-authors (, 2007) 
found that those treated under general anaesthesia were the most anxious; this was 
based on the score of 2 and no statistical analysis. Likewise, Holmes and Girdler (2005) 
reported a statistically significant difference in anxiety scores between sedation and non-
sedation groups; however, success of treatment in both groups were not discussed. 
In the present study, treatment complexity and sedation need were found to not affect 
treatment outcome (treatment completed under inhalation sedation vs treatment 
abandoned and referred to GA). Contrastingly, Liu and co-authors (2013) did report that 
there was a statistically significant difference in the IOSN scores of the treatment 
modalities investigated (LA vs IV vs GA); this difference was only significant when 
comparing between scores of patients referred for treatment under local anaesthesia to 
those receiving treatment under intravenous sedation and general anaesthesia. 
Moreover, they reported that the more invasiveness the treatment modality, the higher 
the sedation need score. Though a similar methodology was followed, Liu and co-
authors (2013) conducted the study on an adult population in a minor oral surgery unit, 
with inhalation sedation not being used. Furthermore, it is unclear how many participants 
completed their treatment under each modality investigated. 
 
4.6 p-IOSN tool  
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The p-IOSN tool is a novel instrument that aims to aid clinical judgement and identify 
those patients that may benefit from sedation, similar to the IOSN tool (Madouh and 
Tahmassebi 2016; Coulthard, 2012; Coulthard et al., 2011).  Therefore, assessing 
whether sedation need, and the other component of the p-IOSN (anxiety, treatment 
complexity and medical status), could be used as a predictor of treatment outcome. 
The results of this current study mirrored that of Madouh and Tahmassebi (2016); there 
was no significant association between anxiety, treatment complexity, and gender when 
compared with treatment outcome. Furthermore, this study adds that sedation need is 
not a reliable predictor for treatment outcome. This may indicate that the p-IOSN 
requires further fine-tuning to improve its accuracy.  
The available treatment modalities for children in use at LDI are as follows: 
1. Treatment using non-pharmacological behaviour management techniques 
with/without the use of local anaesthetic 
2. Treatment under inhalation sedation (mixture of oxygen/nitrous oxide gas) 
3. Treatment under general anaesthesia (comprehensive dental treatment or 
exodontia only) 
4. Intravenous sedation limited to medically fit and well children aged 12 years and 
above 
Indications of conscious sedations as previously discussed include patients who are 
anxious/phobic, those with complex treatment and medical needs, and special needs 
patients. Regarding the patients that attend the sedation clinic, they are referred 
following assessment on new patient clinics by qualified dentists under the supervision 
of a consultant/specialist in paediatric dentistry; the majority are ASA I or ASA II, with a 
variety of treatment needs. Inherently, the patients may present with variable levels of 
anxiety and phobia. 
4.6.1 Anxiety: 
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Two measures are used to assess anxiety in the p-IOSN as developed by Madouh and 
Tahmassebi (2016); FIS for 5-9 years of age and MCDASf for 10-16 years of age. 
However, Howard and Freeman (2007) found that the addition of faces made the 
MCDASf suitable for children as young as 5 years. Nevertheless, the aetiology of anxiety 
is multifactorial. Kain and co-authors (1996), conducted a prospective study where they 
investigated predictors of pre-operative anxiety in children. The anxiety measures 
utilised self-reported and independent observational measures pre-operatively, at 2 
weeks, 6 months and 1 year following treatment under general anaesthesia. They 
concluded predictors of child anxiety include: 
1. Situational anxiety of mother 
2. Temperament of child 
3. Age of child 
4. Quality of previous medical encounters 
Though Kain and co-authors (1996) only examined patients receiving “elective 
ambulatory surgery” under general anaesthesia, the predictors mentioned above may 
still be valid for dental treatment under inhalation sedation. Excluding age of the child, 
the remaining predictors may not be quantified easily. 
Furthermore, the IOSN utilises the MDAS anxiety measure, where a score above 19 
was considered as a “highly” anxious patient. The grading used by the IOSN was 
selected empirically by the authors (Coulthard et al., 2011). Following piloting the 
survey, the authors noted no statistically significant difference between moderate and 
highly anxious patient, with a significant difference between low and moderately anxious 
patients, and the low and highly anxious patients. An issue with the original IOSN tool 
was that though anxiety may be high, sedation need may be scored as moderate hence 
no sedation was required. The conclusion reached by the authors were that the anxiety 
scoring used did not capture all patients and a fourth rating of “very high” was added. 
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(Pretty et al., 2011). Similarly, with the p-IOSN, the anxiety rankings were selected 
arbitrarily (Madouh and Tahmassebi, 2016). 
Though anxiety, fear and phobia have been used interchangeably, they are all different 
identities. Anxiety can be termed as a “pre-stimulus” reaction where it is associated with 
apprehensive anticipation of future danger, where fear is “post stimulus” where a 
predefined stimulus triggering the fear; phobia, on the other hand, requires a clinical 
diagnosis (Porritt et al., 2013; Ohman, 2008). The investigators could not find any 
literature relating to anxiety scores and its correlation to anxiety levels. Additionally, the 
FIS used in the p-IOSN only provides an immediate reflection of how the patient feels 
regarding dental treatment. Other surveys such as the MCDAS and CFSS-DS can help 
distinguish those patients who are highly anxious (Porritt et al., 2013). 
While the IOSN and p-IOSN have graded anxiety from low to high/extremely high, the 
measures they use are only able to distinguish the extremely anxious patients (Madouh 
and Tahmassebi 2016; Pretty et al., 2011). 
4.6.2 Medical status: 
The population in this study was limited in medical complexity, as only ASA I, ASA II, or 
patients with gag reflex were recruited, therefore giving a maximum score of 9. No 
patients were given a final sedation need ranking of very high. A total of 89/97 were 
classified as ASA I with the remaining 8/97 classified as ASA II; those who were 
classified as ASA II were either asthmatic, had a drug allergy or had a gag reflex.  
4.6.3 Treatment complexity 
Similar results were reported by Madouh and Tahmassebi (2016), where treatment 
complexity was not found to be significantly associated with treatment outcome. The 
current study recruited a total of 97 patients, the majority of which were classified as 
complex treatment needs (74/97) followed by highly complex (11/97). As a tertiary 
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service, it may be assumed that patients being referred to the LDI have complex 
treatment needs.  
The results paralleled that of Madouh and Tahmassebi (2016) in which treatment 
complexity was not associated with treatment outcome. Though in adults, treatment 
complexity was found to be predictor of sedation need, the published evidence using 
the IOSN did not look at treatment complexity alone as a predictor of treatment outcome 
(Liu et al., 2013). 
4.6.4 Sedation need: 
In both the p-IOSN and IOSN, sedation is indicated for those scoring high or very high 
need. The current study did not recruit any patients with very high needs as that was not 
achievable with the patients who attended the sedation clinic. The majority of those who 
completed the treatment as planned were categorised as moderate sedation need 
(34/47); similarly, the majority of patients that were referred to have dental treatment 
under general anaesthesia were classified as moderate sedation need (11/20).  
Regarding sedation need, Madouh and Tahmassebi (2016) had similar results. In the 
adult population, however, sedation need was associated with treatment outcome; Liu 
and co-authors (2013) found that the IOSN could predict those that needed sedation vs 
those that do not where 80% of patients were identified as requiring sedation. It should 
be noted that the authors grouped intravenous sedation with general anaesthesia in the 
sedation group when comparing sedation need against treatment under local 
anaesthesia. 
4.7 Clinical implications 
What the current study showed that changing the anxiety of the child could have an 
impact on the OHRQoL. Clinicians can manage anxiety in various ways using both 
pharmacological and non-pharmacological techniques, which should be assessed on 
an individual basis (SDCEP 2012; British Society of Paediatric Dentistry, 2011).  
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Though treatment under sedation may be seen as safer and less costly than treatment 
under general anaesthesia, a Cochrane review published by Ashley and co-authors 
(2015) found that no conclusions could be drawn as there was a lack of robust evidence. 
Jameson and co-authors (Jameson et al., 2007) compared the cost-effectiveness of 
treatment provided under inhalation sedation in primary care versus treatment under 
general anaesthesia in tertiary care. The comparison was based on an average cost per 
child. The results showed that dental treatment under general anaesthesia was about 
1.5 times the price of advanced conscious sedation techniques (£359.91 vs £ 245.47). 
Additionally, the authors also mentioned that waiting times and treatment plans were 
often more favourable with conscious sedation. Furthermore, Jameson and co-authors 
(2007) acknowledged that the population in each group may vary in terms of special 
needs. 
Current literature on repeat general anaesthesia for day-case dental treatment at the 
LDI show a rate of 8.9%; oral pain and infection and irregular attendance were found to 
be potential predictors for repeat general anaesthetics (Kakaounaki et al., 2010). A 
repeat general anaesthetic can have detrimental effects in terms of cost, potential 
morbidity and mortality, and behaviour and emotional effects on the child (Royal College 
of Surgeons of England, 2008). 
4.8 Future research 
The information gained from this research has showed that there are potential 
shortcomings with the p-IOSN and with OHRQoL assessment in children. Below are 
suggestions for future research based on the results of the current study. 
4.8.1 Sample size: 
The sample size was larger in comparison to the previous pilot study (Madouh and 
Tahmassebi, 2016) but was limited in terms of the age range included. This was due to 
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the age requirements of the additional measures used as it was validated for children 
aged 7 years and above.  
With regards to the p-IOSN tool, it may be more beneficial to be utilised on the new 
patient clinic prior to any judgement made as to which treatment modality will be used; 
patients can then be followed-up prospectively. 
4.8.2 Quality of life: 
The results of this current studied showed improvement in quality of life following dental 
treatment; however, no long-term data was collected (i.e. at 6 months, 12 months etc.) 
At present there is no standardised method to assess OHRQoL. Additionally, the 
measure used quantifies a qualitative outcome. Future research in the use of qualitative 
measures may provide more in-depth analysis regarding changes in QoL and their 
experiences following dental treatment such as through the use of focus groups. 
4.8.3 Anxiety measures: 
Currently the p-IOSN utilised 2 forms of anxiety measures (FIS for children younger than 
10 and MCDASf for those 10 years of age and older). This study found that anxiety was 
not a predictor for treatment outcome. As dental anxiety, fear and phobia are all separate 
identities with various aetiologies, an appropriate anxiety measures is needed. Most 
self-reported anxiety measures have a limited focus on situation triggers of anxiety and 
does not consider the theoretical framework of anxiety. One such framework is “The 
Five Areas Model of Anxiety” which considers the following (Porritt et al., 2013): 
1. Unhelpful thoughts 
2. Physical symptoms 
3. Unhelpful behaviours 
4. Feelings 
5. Situational factors (ie parental anxiety) 
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One such tool is the dent al fear survey (DFS), which looks at unhelpful behaviour and 
physical symptoms, though the other factors above are not included. However, the short 
dental anxiety inventory (S-DAI) does assess multiple situations, physical symptoms, 
behavioural and thought aspects of dental anxiety. The S-DAI has only been validated 
for use in the adult population (Porritt et al., 2013). 
4.8.4 p-IOSN: 
As mentioned previously a prospective study recruiting patients from new patient clinics 
may provide further beneficial information. The final p-IOSN score could then be 
compared with the treatment modality which was used to complete the dental treatment. 
Furthermore it can be used by primary care services as a referral tool to the sedation 
department, and analysed in a similar fashion  
4.9 Limitations of Current Study 
1. The participants were recruited following their assessment for suitability to have 
treatment performed under inhalation sedation. This may have led to sample bias. This 
can be corrected by recruiting patients prior to assessment during “new patient clinic 
sessions”. 
2. The follow-up period was limited to 2 weeks following last appointment, showing only 
short term changed in quality of life. Ideally a longer follow-up would be needed. 
3. The QoL measure used limited the patients we could recruit as it was only suitable 
for those aged 7-19 years. Furthermore the questionnaire also was non-specific and 
calculated a general OHRQoL score. 
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5.0 CONCLUSIONS: 
1. Quality of life did improve following dental treatment under IHS, with the largest effect 
noted in the oral health wellbeing domain. 
2. Dental anxiety had a significantly negative impact on OHRQoL. 
3. The factors assessed, such as anxiety, treatment complexity, age, gender and 
sedation need were not found to be significant predictors of treatment outcome. 
 
Therefore, we can accept the following null hypothesis: 
 There is no statistically significant association between p-IOSN score and outcome 
of treatment. 
 There is no statistically significant association between baseline quality of life and 
gender, treatment complexity, sedation need and age. 
We can reject the following null hypothesis 
 There is no statistically significant difference in quality of life before and after 
treatment. 
 There is no statistically significant association between baseline quality of life and 
anxiety.
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Appendix 1: DREC approval and recommendation: 
 
 
NRES Committee West Midlands - Solihull 
The Old Chapel 
Royal Standard Place 
Nottingham 
NG1 6FS 
 
Telephone: 0115 8839436 
 
05 June 2014 
 
Mr Ahmed S. Altimimi 
Flat 24 Bedford Chambers 18 Bedford Street 
18 Bedford Street 
Leeds 
LS1 5PZ 
 
 
Dear Mr Altimimi  
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Study title: Outcome of treatment and  changes in quality of life with 
treatment under inhalation sedation 
REC reference: 14/WM/1019 
IRAS project ID: 149819 
 
Thank you for your application for ethical review, which was received on 03 June 2014.  I can 
confirm that the application is valid and will be reviewed by the Proportionate Review Sub-
Committee on 11 June 2014.  To enable the Proportionate Review Sub Committee to provide 
you with a final opinion within 10 working days your application documentation will be sent to 
Committee members. 
 
One of the REC members is appointed as the lead reviewer for each application reviewed by 
the Sub-Committee.   
 
Please note that the lead reviewer may wish to contact you by phone or email between 
Monday 9 June and  Wednesday 11 June to clarify any points that might be raised by members 
and assist the Sub-Committee in reaching a decision. 
 
If you will not be available between these dates, you are welcome to nominate another key 
investigator or a representative of the study sponsor who would be able to respond to the lead 
reviewer’s queries on your behalf.  If this is your preferred option, please identify this person 
to us and ensure we have their contact details. 
 
You are not required to attend a meeting of the Proportionate Review Sub-Committee. 
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Please do not send any further documentation or revised documentation prior to the review 
unless requested. 
 
Documents received 
 
The documents to be reviewed are as follows: 
 
Document   Version   Date     
Evidence of Sponsor insurance or indemnity (non NHS Sponsors 
only) [Liability and PI confirmation]  
1  19 September 2013    
IRAS Checklist XML [Checklist_03062014]    03 June 2014    
IRAS Checklist XML [Checklist_04062014]    04 June 2014    
Letter from statistician [Letter from statistician]  1  03 June 2014    
Other [Data sheet]  1  28 May 2014    
Other [Prof Monty CV Summary]  1  04 June 2014    
Participant consent form [Appendix 5: Assent form (for patients 10-
16 years old) ]]  
3  28 May 2014    
Participant consent form [Assent form for children age 7-9]  3  28 May 2014    
Participant consent form [Consent form]  1  28 May 2014    
Participant information sheet (PIS) [Parents information sheet]  2  28 May 2014    
  
112 
Participant information sheet (PIS) [Appendix 2: Childâ€™s 
information sheet (ages 10-16)]  
2  28 May 2014    
REC Application Form [REC_Form_03062014]    03 June 2014    
Research protocol or project proposal [Protocol ]  6  28 May 2014    
Summary CV for Chief Investigator (CI) [Summary of CV]  1  02 June 2014    
Summary CV for supervisor (student research) [Dr Jinous CV 
Summary]  
1  02 June 2014    
Summary, synopsis or diagram (flowchart) of protocol in non 
technical language [Summary of protocol of research]  
1  02 June 2014    
Validated questionnaire [Appendix 10:   Child Oral Health Impact 
Profile Short form (COHIP-SF19) ]  
1  28 May 2014    
Validated questionnaire [Appendix 8:  The paediatric version of the 
Indicator of Sedation Need (p-IOSN)]  
1  28 May 2014    
Validated questionnaire [Appendix 7:   Faces version of the Modified 
Child Dental Anxiety Scale (MCDASf)  (for 10 to 16 years old patients) 
]  
1  28 May 2014    
Validated questionnaire [Appendix 6:   Facial Image Scale (FIS) (for 
7 to 9 years old patients)]  
1  28 May 2014    
 
 
No changes may be made to the application before the meeting. If you envisage that changes 
might be required, you are advised to withdraw the application and re-submit it. 
 
Notification of the Sub-Committee’s decision 
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We aim to notify the outcome of the Sub-Committee review to you in writing within 10 working 
days from the date of receipt of a valid application. 
 
If the Sub-Committee is unable to give an  opinion because the application raises material 
ethical issues requiring further discussion at a full meeting of a Research Ethics Committee, 
your application will be referred for review to the next available  meeting.  We will contact you 
to explain the arrangements for further review and check they are convenient for you.  You 
will be notified of the final decision within 60 days of the date on which we originally received 
your application.  If the first available meeting date offered to you is not suitable, you may 
request review by another REC.  In this case the 60 day clock would be stopped and restarted 
from the closing date for applications submitted to that REC. 
 
R&D approval 
 
All researchers and local research collaborators who intend to participate in this study at sites 
in the National Health Service (NHS) or Health and Social Care (HSC) in Northern Ireland 
should apply to the R&D office for the relevant care organisation.  A copy of the Site-Specific 
Information (SSI) Form should be included with the application for R&D approval.  You should 
advise researchers and local collaborators accordingly.   
 
The R&D approval process may take place at the same time as the ethical review.  Final R&D 
approval will not be confirmed until after a favourable ethical opinion has been given by this 
Committee. 
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For guidance on applying for R&D approval, please contact the NHS R&D office at the lead 
site in the first instance.  Further guidance resources for planning, setting up and conducting 
research in the NHS are listed at http://www.rdforum.nhs.uk.  There is no requirement for 
separate Site-Specific Assessment as part of the ethical review of this research. 
 
Communication with other bodies 
 
All correspondence from the REC about the application will be copied to the research sponsor 
and to the R&D office. It will be your responsibility to ensure that other investigators, research 
collaborators and NHS care organisation(s) involved in the study are kept informed of the 
progress of the review, as necessary. 
 
We are pleased to welcome researchers and R & D staff at our NRES committee members’ 
training days – see details at http://www.hra.nhs.uk/hra-training/  
 
14/WM/1019   Please quote this number on all correspondence 
 
Yours sincerely 
 
 
 
Joanne Unsworth 
REC Assistant 
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Email: nrescommittee.westmidlands-solihull@nhs.net  
 
Copy to: Ms Ann Gowing, Leeds R&D LTHT 
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Appendix 2a: Ethical Approval Letter 
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Appendix 2b: Amendment Approval 
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Appendix 3: R&D approval: 
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Appendix 4: Parent’s information sheet [V.3] 
Research Title 
A research project to help dentists and health care providers to recognise people who are in 
need of sedation in order to carry out their dental treatment and the effect it may have on the 
quality of life 
Introduction 
You and your child are invited to take part in the above research study at Leeds Dental 
Institute. 
Before you decide whether or not to take part, please take time to read the following 
information carefully in order to understand what this research is about and what your 
participation involves. Please feel free to discuss with other people and ask us if you wish to 
clarify any matters regarding this research. Taking part in the study will approximately add 5-
10 minutes to your appointment.  
Study Purpose 
The purpose of this study is to help dentists and dental care providers to identify who are in 
need sedation in order to carry out their dental treatment in order to ensure that sedation is 
used fittingly. Additionally, we shall look at the effect of treatment under sedation on the quality 
of life also. This study will be funded by the Faculty of Medicine and Health, University of 
Leeds. 
Some Questions You May Have 
Why have I been chosen? 
You and your child have been chosen because your child is attending their first visit in the 
sedation unit at Leeds Dental Institute. 
Do I have to take part? 
You are not obliged to participate and this won’t affect the treatment that your child is 
going to receive. We will go through this information sheet and explain this study to you. A 
copy of the consent form shall be sent to you by post. If you decide to take part, a signed 
consent form is needed by the next appointment, although you are free to withdraw from the 
study at any time without giving a reason. If you wish to receive the summary of the results, 
we can send it to you by post if requested 
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What do I have to do? 
We would like to ask your child some questions about how they feel at the moment (i.e. being 
at the dentist). The answer(s) to the question(s) will then be to our assessment form for the 
project. Afterwards, a comparison is done between your child’s answers and the notes in their 
file. Your child would also be interviewed at the first visit, and two weeks after the last 
appointment to see how the treatment he/she had affected their quality of life. 
 
What are the possible benefits of taking part? 
We hope to understand more about how your child feels about the treatment and by taking 
part we can find out who would need sedation and recognise this earlier. Moreover, at the two 
week review, fluoride paste will be applied on their teeth to help strengthen them. 
What will happen if I decided not to continue with the study? 
You can withdraw from the study at any time; this won’t affect your child’s treatment in any 
way. Unless you ask us not to, the information already collected shall be used in the analysis.  
What will happen to the result of the research? 
The information will be stored safely and securely in the usual manner that all other clinical 
data/records are stored. Any personal data collected shall be kept confidential. Furthermore, 
the results of this study are intended to be used for professional doctorate research project by 
Ahmed Altimimi, and possibly published in Dental Journals and presented at conferences. 
There will be no mention of specific individuals.  
What if I need to complain? 
The normal complaints process will apply. You can have more information on the NHS Patient 
Advice and Liaison Service (PALS) website [http://www.pals.nhs.uk/]. You can also contact 
the local PALS office in Leeds; their contact details are as follows: 
Telephone: 0800 0525270 
Email: pals@leedspct.nhs.uk  
Office Address: 
Patient Advice and Liaison Service 
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NHS Leeds 
1st floor rear 
North West House 
West Park Ring Road 
Leeds 
West Yorkshire 
ENGLAND 
LS16 6QG 
 
Who is organising and funding this research? 
This research is funded by the Faculty of Medicine and Health, University of Leeds. 
Who reviewed this study? 
The University of Leeds has reviewed the study. This study has been approved by  NRES 
Committee West Midlands - Solihull Ethical committee. 
Who can I contact for further information? 
If you have further questions, you can contact Mr. Ahmed S. Altimimi or the lead supervisor, 
Dr Jinous Tahmassebi, through the following methods: 
 
Mr Ahmed S. Altimimi: 
Email:   dnasal@leeds.ac.uk  
Telephone:  07885603926 
Dr Jinous Tahmassebi: 
Email:  J.Tahmassebi@leeds.ac.uk  
Telephone:  01133433955 
Thank you 
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Appendix 5: Child’s information sheet (ages 10-16) [V.3] 
Research Title 
A project to help dentists and health care workers find a way to see who needs laughing gas 
in order to fix their teeth and the effect it may have on how you feel about your teeth. 
Introduction 
We are asking if you would join in a research project to find the answer to the question. 
‘Who needs laughing gas in order to fix their teeth and does it affect how you feel about your 
teeth?’ 
Before you decide if you want to join in, it’s important to understand why the research is being 
done and what it will involve for you. So please consider this leaflet carefully. Talk to your 
family, friends, doctor or nurse if you want to.  
Study Purpose 
This project aims at helping dentists and dental care workers to see which people need 
laughing gas to have their teeth fixed. Also, the effect that laughing gas has is going to be 
checked. 
Some Questions You May Have 
Why have I been chosen? 
We chose you because you are here in the clinic today to have your teeth fixed. You will help 
us find out who needs to have laughing gas to fix their teeth. 
Do I have to take part? 
No. It is up to you. We will ask you for your permission and signature on our information forms. 
If you decide to take part, a copy of this information sheet and your signed form to is given to 
you. You are free to stop taking part at any time during the research without giving a reason. 
If you decide to stop, this will not affect how we fix your teeth.  
 
What do I have to do? 
You would need to answer some questions about how you are feeling, the answered will be 
compared to the work that the dentist did. Also, we would ask you to answer some questions 
on how you feel about your teeth at your first appointment and 2 weeks after your last 
appointment. 
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What are the benefits of taking part? 
We hope to understand more about how you feel about the treatment and by taking part we 
can find out who are the children that need sedation and recognise this earlier. We will also 
be applying some special fluoride paste on your teeth at the end of the study. 
 
What will happen if I decided not to continue with the study? 
You can stop from the study at any time; this will not change your treatment in any way. Unless 
told not to, we will use the information already collected.  
Who can I contact for further information? 
If you have further questions, you can contact Mr. Ahmed S. Altimimi or the lead supervisor, 
Dr Jinous Tahmassebi, through the following methods: 
 
Ahmed S. Altimimi 
Email:   dnasal@leeds.ac.uk  
Telephone:  07885603926 
Dr Jinous Tahmassebi: 
Email:  J.Tahmassebi@leeds.ac.uk  
Telephone:  01133433955 
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Copies: 
Once this has been signed by all parties the participant should receive a copy of the signed and dated 
participant consent form, the letter/pre-written script/information sheet and any other written 
information provided to the participants. A copy of the signed and dated consent form should be kept 
with the project’s main documents which must be kept in a secure location.  
 
Appendix 6:  Consent form [V.1] 
Patient Identification Number/Name: 
Project Title:  
A project to help dentists and health care workers find a way to see who needs inhalation 
sedation in order to fix their teeth and the effect it may have on their everyday life  
 Please initial the box if you agree with the statement to the left. 
1 I confirm that I have read and understand the information sheet/letter  
explaining the above research project and I have had the opportunity to ask 
questions about the project. 
 
 
2 I understand that my participation and my child’s are voluntary and that we are 
free to withdraw at any time without giving any reason and without there being any 
negative consequences. In addition, should we not wish to answer any particular 
question or questions, we are free to decline.                                                     
  
3 I understand that my child’s name will not be linked with 
the research materials, and we will not be identified or identifiable in the 
report or reports that result from the research.  
  
4 I agree my child’s notes can be looked at by the researchers   
5 I agree for the data collected from our participation can be used in future research 
and for educating dentist and the dental team. 
  
6 I and my child agree to take part in the above research project.   
7 I would like to receive a simple summary of the results by post   
________________________ ________________     ____________________ 
Name of participant Date  Signature 
(or legal representative and relationship) 
 
Lead researcher                                          Date  Signature 
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Appendix 7: Assent form (for patients 7-9 years old) [V.3] 
 
  
 
Hi! My name is Ahmed, and I 
have a project. I need help 
Can you help me with my project please? Circle one 
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Appendix 8: Assent form (for patients 10-16 years old) [V.3] 
Patient Identification Number/Name: 
Project Title:  
A project to help dentists and health care workers find a way to see who needs laughing gas 
in order to fix their teeth and the effect it may have on how you feel about your teeth 
Please circle all that you agree with (if you are unable to do so, your parents may help you).  
Have you read (or had read to you) about this project?  Yes/No 
  
Has somebody else explained this project to you?  Yes/No 
  
Do you understand what this project is about?  Yes/No 
  
Have you asked all the questions you want?  Yes/No 
  
Do you understand all the answers to your questions?  Yes/No 
  
Do you understand it’s OK to stop taking part at any time?  Yes/No 
  
Are you happy to take part?  Yes/No 
 
If any answers are ‘No’ or you do not want to take part, don’t sign your name!  
If you do want to take part, you can write your name on the next page  
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Name (Block Capitals):   _________________________ 
Child’s Signature:   _________________________ 
Date:     _________________________ 
  
Name (Block Capitals):   _________________________ 
Parent/Guardian Signature: _________________________ 
Date:     _________________________ 
 
The dentist who explained this project to you needs to sign too:  
 
Name (Block Capitals):  _________________________ 
Signature:    _________________________ 
Date:     _________________________ 
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Appendix 9:   Facial Image Scale (FIS) (for 7 to 9 years old patients) 
[V.1] 
Please circle the “face” that is most applicable to you now: 
 
Thank you 
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Appendix 10:   Faces version of the Modified Child Dental Anxiety 
Scale (MCDASf)  (for 10 to 16 years old patients) [V.1] 
 
For the next eight questions I would like you to show me how relaxed or worried you get about 
the dentist and what happens at the dentist. To show me how relaxed or worried you feel, 
please use the simple scale below. The scale is like a ruler going from 1which would show 
that you are relaxed, to 5 which would show that you are very worried. 
1 would mean: relaxed/not worried 
2 would mean: very slightly worried 
3 would mean: fairly worried 
2 would mean: worried a lot  
3 would mean: very worried 
 
Please circle the most applicable number to each of the following questions: 
 
Thank you 
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Appendix 11:  The paediatric version of the Indicator of Sedation 
Need (p-IOSN) [V.1] 
 
Patient serial number: 
p-IOSN domain Possible score Patient’s Score 
Anxiety 1-3  
Treatment Complexity 1-4  
Medical status 1-4  
Total p-IOSN score  
Sedation Need:  
 
 
Key: 
p-IOSN metric p-IOSN description  Sedation need? 
3-4 Minimal need for sedation  No 
5-6 Moderate need for sedation  No  
7-9 High need for sedation Yes  
10-11 Very high need for sedation Yes  
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Appendix 12:   Data Collection Sheet  [V.1] 
 1 2 3 4 5 6 7 8 9 10 11 12 13 
Personal details              
Age              
Gender (m:0, f:1)              
Patient’s p-IOSN score Anxiety score              
Tx Complexity              
Medical status              
Total              
Treatment outcomes              
Completed as planned (0)              
Modified treatment completed (1)               
Tx abandoned and child referred to be treated under GA (3)              
Treatment abandoned in sedation unit and child referred to be 
treated under local anaesthesia (4) 
             
Child failed to return to complete treatment (5)              
Quality of Life score before treatment              
Quality of Life score after treatment              
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Domains Scoring 
Oral Health – Well-Being 0= Almost all the time 1= Fairly often 2= Sometimes 3= Almost never 4= Never 
Q1. Had pain in your tooth/teeth?      
Q2. Had discoloured teeth or spots on your teeth?      
Q3. Had crooked teeth or spaces between your teeth?      
Q4. Had bad breath?      
Q5. Had bleeding gums      
Functional Well-Being 0= Almost all the time 1= Fairly often 2= Sometimes 3= Almost never 4= Never 
Q6. Had difficulty eating food you would like to eat      
Q7. Had trouble sleeping      
Q8. Had difficulty saying certain words      
Q9. Had difficulty keeping your teeth clean      
Social-Emotional Well-Being 0= Almost all the time 1= Fairly often 2= Sometimes 3= Almost never 4= Never 
Q10. Been unhappy or sad      
Q11. Felt worried or anxious      
Q12. Avoided smiling or laughing      
Q13. Felt that you looked different      
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Appendix 13:   Child Oral Health Impact Profile Short form (COHIP-SF19) [V.1]
Q14. Been worried about what the people think about your 
teeth, mouth or face 
     
Q15. Been teased, bullied, or called names by other 
children 
     
Q16. Missed school for any reason      
Q17. Not wanted to speak/read out loud in class      
 0= Never 1= Almost never 2= Sometimes 3=  Fairly often 4=  Almost all the time 
Q18. Been confident      
Q19. Felt that you were attractive (good looking)      
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